201
|
Gong D, Tan Z, Zhao H, Pan Z, Sun Q, Qiu F. Fine mapping of a kernel length-related gene with potential value for maize breeding. Theor Appl Genet 2021; 134:1033-1045. [PMID: 33459823 DOI: 10.1007/s00122-020-03749-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Accepted: 12/09/2020] [Indexed: 06/12/2023]
Abstract
A key candidate gene for maize kernel length was fine mapped to an interval of 942 kb; the locus significantly increases kernel length (KL) and hundred-kernel weight (HKW). Kernel size is a major determinant of yield in cereals. Kernel length, one of the determining factors of kernel size, is a target trait for both domestication and artificial breeding. However, there are few reports of fine mapping and quantitative trait loci (QTLs)/cloned genes for kernel length in maize. In this project, a novel major QTL, named qKL9, controlling maize kernel length was identified. We verified the authenticity and stability of qKL9 via BC2F2 and BC3F1 populations, respectively, and ultimately mapped qKL9 to an ~ 942-kb genomic interval by testing the progenies of recombination events derived from BC3F2 and BC4F2 populations in multiple environments. Additionally, one new line (McqKL9-A) containing the ~ 942-kb segment was screened from the BC4F2 population. Combining transcriptome analysis between McqKL9-A and Mc at 6, 9 and 14 days after pollination and candidate regional association mapping, Zm00001d046723 was preliminarily identified as the key candidate gene for qKL9. Importantly, the replacement in the Mc line of the Mc's alleles by the V671's alleles in the qKL9 region improved the performances of single-cross hybrids obtained with elite lines, illustrating the potential value of this QTL for the genetic improvement in maize kernel-related traits. These findings facilitate molecular breeding for kernel size and cloning of the gene underlying qKL9, shedding light on the genetic basis of kernel size in maize.
Collapse
Affiliation(s)
- Dianming Gong
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, No.1, Shizishan Street, Hongshan District, Wuhan, 430070, People's Republic of China
| | - Zengdong Tan
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, No.1, Shizishan Street, Hongshan District, Wuhan, 430070, People's Republic of China
| | - Hailiang Zhao
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, No.1, Shizishan Street, Hongshan District, Wuhan, 430070, People's Republic of China
| | - Zhenyuan Pan
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, No.1, Shizishan Street, Hongshan District, Wuhan, 430070, People's Republic of China
| | - Qin Sun
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, No.1, Shizishan Street, Hongshan District, Wuhan, 430070, People's Republic of China
| | - Fazhan Qiu
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, No.1, Shizishan Street, Hongshan District, Wuhan, 430070, People's Republic of China.
| |
Collapse
|
202
|
Sun Q, Wang B, Zhu CJ, Mou FJ, Yin ZY, Wang PP, Chen XN, Chen RJ, Liu Y, Li F, Tao L. [Evaluation of the safety and efficacy of transcatheter aortic valve replacement with domestic prostheses for patients with severely stenotic bicuspid aortic valve]. Zhonghua Xin Xue Guan Bing Za Zhi 2021; 49:250-256. [PMID: 33706459 DOI: 10.3760/cma.j.cn112148-20200902-00698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the safety and efficacy of transcatheter aortic valve replacement (TAVR) with domestic prostheses in patients with severely stenotic bicuspid aortic valve (BAV). Methods: This study was a prospective single-center non-randomized controlled study. Patients with symptomatic severe aortic stenosis (AS), who underwent TAVR with domestic prostheses at the First Affiliated Hospital of Air Force Medical University from January 2016 to April 2020 were consecutively included in our study. Patients were divided into BAV group and tricuspid aortic valve (TAV) group according to the aortic valve morphology. Baseline characteristics, procedural outcomes were compared between the two groups, and the primary endpoint was one-month all-cause mortality. Results: A total of 100 patients aged (69.8±8.9) years were enrolled, including 71 (71%) males. There were 51 cases in BAV group and 49 cases in TAV group. Compared with TAV group, patient in the BAV group was younger ((67.1±8.6) years vs. (72.7±8.4) years, P=0.002) and had larger ascending aortic diameter at proximal part ((39.7±5.7) mm vs. (36.0±4.2) mm, P<0.001), lower Society of Thoracic Surgeons-Predicted Risk of Mortality (STS-PROM) score (3.1 (1.9, 5.4) % vs. 5.9 (2.6, 12.3) %, P=0.002). In BAV group and TAV group, the incidence of 2nd prosthesis implantation was 15.7% (8/51) and 18.4% (9/49) (P=0.721), the incidence of moderate or severe paravalvular regurgitation was 2.0% (1/51) and 0 (P=1.000), the rate of device success was 82.4% (42/51) and 81.6% (40/49) (P=0.925), respectively. One-month all-cause mortality was 2.0% (1/51) and 10.2% (5/49) (P=0.108), respectively. Echocardiography showed that postprocedural mean pressure gradient (PGmean) was higher in the BAV group (13.0 (10.0, 16.0) mmHg vs. 9.0 (7.0, 14.0) mmHg, P=0.003) (1 mmHg=0.133 kPa), but the PGmean decrease post procedure as compared with that before TAVR was similar between the two groups ((36.7±16.6) mmHg vs. (36.2±17.5) mmHg, P=0.893). Conclusion: Favorable safety and efficacy are evidenced in patients with severely stenotic BAV undergoing TAVR with domestic prostheses.
Collapse
Affiliation(s)
- Q Sun
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - B Wang
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - C J Zhu
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - F J Mou
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - Z Y Yin
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - P P Wang
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - X N Chen
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - R J Chen
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - Y Liu
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - F Li
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| | - L Tao
- Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
| |
Collapse
|
203
|
Han CQ, Xia YY, Sun Q, Zou QG. Improved Synthesis of Bepotastine Besilate. ORG PREP PROCED INT 2021. [DOI: 10.1080/00304948.2020.1868930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- C. Q. Han
- School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China
| | - Y. Y. Xia
- School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China
| | - Q. Sun
- School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China
| | - Q. G. Zou
- School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China
| |
Collapse
|
204
|
Sun Q, Li T, Li Y, Wei L, Zhang M, Deng S. Bactericidal/Permeability-Increasing Protein Improves Cognitive Impairment in Diabetic Mice via Blockade of the LPS-LBP-TLR4 Signaling Pathway. Front Physiol 2021; 11:718. [PMID: 33643054 PMCID: PMC7905103 DOI: 10.3389/fphys.2020.00718] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Accepted: 05/29/2020] [Indexed: 01/23/2023] Open
Abstract
Emerging evidence suggests that the bactericidal/permeability-increasing protein (BPI) is involved in the process of cognitive impairment in diabetes. However, its underlying mechanism remains elusive. In this study, we found that BPI affects cognitive impairment due to diabetes through the lipopolysaccharide (LPS)-lipopolysacharide-binding protein (LBP)-toll-like receptor 4 (TLR4) signaling pathway. We examined the expression of BPI, LPS, LBP, CD14, and TLR4 in established mouse models of diabetes induced by high-fat diet (HFD) in combination with streptozotocin (STZ). Diabetic mice were then injected with adeno-associated-virus carrying BPI overexpression vectors and LPS. Fasting blood glucose, plasma insulin, and serum levels of inflammatory factors were examined. Then, glucose tolerance and, insulin resistance tests were used to measure systemic insulin sensitivity. Next, hippocampal tissue injury and cell apoptosis were examined by hematoxylin-eosin (HE) and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining. Diabetic mice displayed increased LPS expression and activation of the LPS-CD14-TLR4 signaling pathway. HFD mice following LPS treatment showed significantly increased serum levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6, and expressions of Bcl-2-associated X protein (Bax) and Aβ but decreased expression of Bcl-2 in hippocampal tissues, as well as enhanced fasting blood glucose, plasma insulin, glucose tolerance, insulin tolerance, cell apoptosis, aggravated hippocampal tissue injury and, ultimately, cognitive impairment. However, overexpression of BPI was able to rescue the aforementioned phenotypes driven by LPS treatment. Taken together, BPI could potentially provide relief from cognitive impairment in diabetic mice by disrupting the LPS-LBP-TLR4 signaling pathway, underscoring a possible alternative therapeutic strategy against the cognitive impairment associated with diabetes.
Collapse
Affiliation(s)
- Qin Sun
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.,Center of Diabetes Mellitus, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
| | - Tingxin Li
- Health Management Center, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
| | - Yamei Li
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - Lingling Wei
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - Min Zhang
- Center of Diabetes Mellitus, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
| | - Shaoping Deng
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.,Center of Diabetes Mellitus, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
| |
Collapse
|
205
|
Li X, Cheng M, Sun Q, Wu Y, Zhang X, Hou J. P59.04 Sex-Related Differences in Genomic and Immune Profiling of Lung Adenocarcinoma. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
206
|
Abstract
Background Midkine is a multi-functional molecule participating in a various key pathological process. We aimed to evaluate the change of midkine in sepsis and its association with angiotensin-converting enzyme (ACE) system, as well as the mechanism by which midkine induced in sepsis and lung injury. Methods The peripheral blood sample of septic patients on admission was obtained and measured for midkine, ACE and angiotensin II. Cecal ligation and puncture (CLP) mouse model was used, and adeno-associated virus (AAV) was stilled trans-trachea for regional targeting midkine expression, comparing the severity of lung injury. Furthermore, we studied the in vitro mechanism of midkine activates ACE system by using inhibitors targeting candidate receptors of midkine, and its effects on the vascular endothelial cells. Results Plasma midkine was significantly elevated in sepsis, and was closely associated with ACE system. Both circulating and lung midkine was increased in CLP mouse, and was related to severe lung injury. Regional interfering midkine expression in lung tissue by AAV could alleviate acute lung injury in CLP model. In vitro study elucidated that Notch 2 participated in the activation of ACE system and angiotensin II release, induced by midkine and triggered vascular endothelial injury by angiotensin II induced reactive oxygen species production. Conclusions Midkine inhibition ameliorates sepsis induced lung injury, which might via ACE/Ang II pathway and the participation of Notch 2 in the stimulation of ACE. Trial registration Clinicaltrials.gov NCT02605681. Registered 12 November 2015
Collapse
Affiliation(s)
- Jing-Yuan Xu
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd., Nanjing, 210009, People's Republic of China
| | - Wei Chang
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd., Nanjing, 210009, People's Republic of China
| | - Qin Sun
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd., Nanjing, 210009, People's Republic of China
| | - Fei Peng
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd., Nanjing, 210009, People's Republic of China
| | - Yi Yang
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd., Nanjing, 210009, People's Republic of China.
| |
Collapse
|
207
|
Aguilar M, Cavasonza LA, Allen MS, Alpat B, Ambrosi G, Arruda L, Attig N, Barao F, Barrin L, Bartoloni A, Başeğmez-du Pree S, Battiston R, Behlmann M, Beranek B, Berdugo J, Bertucci B, Bindi V, Bollweg K, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Burmeister S, Cai XD, Capell M, Casaus J, Castellini G, Cervelli F, Chang YH, Chen GM, Chen GR, Chen HS, Chen Y, Cheng L, Chou HY, Chouridou S, Choutko V, Chung CH, Clark C, Coignet G, Consolandi C, Contin A, Corti C, Cui Z, Dadzie K, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Di Felice V, Díaz C, Dimiccoli F, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Feng J, Fiandrini E, Fisher P, Formato V, Freeman C, Galaktionov Y, Gámez C, García-López RJ, Gargiulo C, Gast H, Gervasi M, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Haino S, Han KC, Hashmani RK, He ZH, Heber B, Hsieh TH, Hu JY, Incagli M, Jang WY, Jia Y, Jinchi H, Kanishev K, Khiali B, Kim GN, Kirn T, Konyushikhin M, Kounina O, Kounine A, Koutsenko V, Kuhlman A, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Li JQ, Li M, Li Q, Li S, Li JH, Li ZH, Liang J, Light C, Lin CH, Lippert T, Liu JH, Liu Z, Lu SQ, Lu YS, Luebelsmeyer K, Luo JZ, Luo X, Lyu SS, Machate F, Mañá C, Marín J, Marquardt J, Martin T, Martínez G, Masi N, Maurin D, Menchaca-Rocha A, Meng Q, Mikhailov VV, Mo DC, Molero M, Mott P, Mussolin L, Negrete J, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Paniccia M, Pashnin A, Pauluzzi M, Pensotti S, Phan HD, Piandani R, Plyaskin V, Poluianov S, Qin X, Qu ZY, Quadrani L, Rancoita PG, Rapin D, Conde AR, Robyn E, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Schael S, Schulz von Dratzig A, Schwering G, Seo ES, Shakfa Z, Shan BS, Siedenburg T, Solano C, Song JW, Song XJ, Sonnabend R, Strigari L, Su T, Sun Q, Sun ZT, Tacconi M, Tang XW, Tang ZC, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Tüysüz C, Urban T, Usoskin I, Vagelli V, Vainio R, Valencia-Otero M, Valente E, Valtonen E, Vázquez Acosta M, Vecchi M, Velasco M, Vialle JP, Wang CX, Wang L, Wang LQ, Wang NH, Wang QL, Wang S, Wang X, Wang Y, Wang ZM, Wei J, Weng ZL, Wu H, Xiong RQ, Xu W, Yan Q, Yang Y, Yashin II, Yi H, Yu YM, Yu ZQ, Zannoni M, Zhang C, Zhang F, Zhang FZ, Zhang JH, Zhang Z, Zhao F, Zheng C, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zuccon P. Properties of Heavy Secondary Fluorine Cosmic Rays: Results from the Alpha Magnetic Spectrometer. Phys Rev Lett 2021; 126:081102. [PMID: 33709764 DOI: 10.1103/physrevlett.126.081102] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2020] [Accepted: 01/22/2021] [Indexed: 06/12/2023]
Abstract
Precise knowledge of the charge and rigidity dependence of the secondary cosmic ray fluxes and the secondary-to-primary flux ratios is essential in the understanding of cosmic ray propagation. We report the properties of heavy secondary cosmic ray fluorine F in the rigidity R range 2.15 GV to 2.9 TV based on 0.29 million events collected by the Alpha Magnetic Spectrometer experiment on the International Space Station. The fluorine spectrum deviates from a single power law above 200 GV. The heavier secondary-to-primary F/Si flux ratio rigidity dependence is distinctly different from the lighter B/O (or B/C) rigidity dependence. In particular, above 10 GV, the F/Si/B/O ratio can be described by a power law R^{δ} with δ=0.052±0.007. This shows that the propagation properties of heavy cosmic rays, from F to Si, are different from those of light cosmic rays, from He to O, and that the secondary cosmic rays have two classes.
Collapse
Affiliation(s)
- M Aguilar
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - L Ali Cavasonza
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - M S Allen
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - B Alpat
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - G Ambrosi
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - L Arruda
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1649-003 Lisboa, Portugal
| | - N Attig
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, 52425 Jülich, Germany
| | - F Barao
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1649-003 Lisboa, Portugal
| | - L Barrin
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | | | - S Başeğmez-du Pree
- Kapteyn Astronomical Institute, University of Groningen, P.O. Box 800, 9700 AV Groningen, Netherlands
| | - R Battiston
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| | - M Behlmann
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - B Beranek
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - J Berdugo
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - B Bertucci
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - V Bindi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - K Bollweg
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - B Borgia
- INFN Sezione di Roma 1, 00185 Roma, Italy
- Università di Roma La Sapienza, 00185 Roma, Italy
| | - M J Boschini
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
| | - M Bourquin
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - E F Bueno
- Kapteyn Astronomical Institute, University of Groningen, P.O. Box 800, 9700 AV Groningen, Netherlands
| | - J Burger
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | | | - S Burmeister
- Institut für Experimentelle und Angewandte Physik, Christian-Alberts-Universität zu Kiel, 24118 Kiel, Germany
| | - X D Cai
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Capell
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J Casaus
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | | | - Y H Chang
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
- Physics Department and Center for High Energy and High Field Physics, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - G M Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - G R Chen
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - H S Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - Y Chen
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - L Cheng
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - H Y Chou
- Physics Department and Center for High Energy and High Field Physics, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - S Chouridou
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - V Choutko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C H Chung
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Clark
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Coignet
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - C Consolandi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Contin
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - C Corti
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - Z Cui
- Shandong University (SDU), Jinan, Shandong, 250100, China
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - K Dadzie
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C Delgado
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | - M B Demirköz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - L Derome
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | | | - V Di Felice
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - C Díaz
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | - P von Doetinchem
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Dong
- Southeast University (SEU), Nanjing, 210096, China
| | - F Donnini
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - M Duranti
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - A Egorov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Eline
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J Feng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - E Fiandrini
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - P Fisher
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Formato
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - C Freeman
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - Y Galaktionov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C Gámez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - R J García-López
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - C Gargiulo
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - H Gast
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - M Gervasi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - F Giovacchini
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - D M Gómez-Coral
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - J Gong
- Southeast University (SEU), Nanjing, 210096, China
| | - C Goy
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - V Grabski
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, 01000 Mexico
| | - D Grandi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - M Graziani
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - S Haino
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - K C Han
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan, 32546, Taiwan
| | - R K Hashmani
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - Z H He
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - B Heber
- Institut für Experimentelle und Angewandte Physik, Christian-Alberts-Universität zu Kiel, 24118 Kiel, Germany
| | - T H Hsieh
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J Y Hu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - M Incagli
- INFN Sezione di Pisa, 56100 Pisa, Italy
| | - W Y Jang
- CHEP, Kyungpook National University, 41566 Daegu, Korea
| | - Yi Jia
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Jinchi
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan, 32546, Taiwan
| | | | - B Khiali
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - G N Kim
- CHEP, Kyungpook National University, 41566 Daegu, Korea
| | - Th Kirn
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - M Konyushikhin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - O Kounina
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kounine
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Koutsenko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kuhlman
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Kulemzin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - G La Vacca
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - E Laudi
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - G Laurenti
- INFN Sezione di Bologna, 40126 Bologna, Italy
| | - I Lazzizzera
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| | - A Lebedev
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H T Lee
- Academia Sinica Grid Center (ASGC), Nankang, Taipei, 11529, Taiwan
| | - S C Lee
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - J Q Li
- Southeast University (SEU), Nanjing, 210096, China
| | - M Li
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - Q Li
- Southeast University (SEU), Nanjing, 210096, China
| | - S Li
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - J H Li
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Z H Li
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - J Liang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - C Light
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C H Lin
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - T Lippert
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, 52425 Jülich, Germany
| | - J H Liu
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing, 100190, China
| | - Z Liu
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - S Q Lu
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - Y S Lu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - K Luebelsmeyer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - J Z Luo
- Southeast University (SEU), Nanjing, 210096, China
| | - Xi Luo
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - S S Lyu
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - F Machate
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Mañá
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J Marín
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J Marquardt
- Institut für Experimentelle und Angewandte Physik, Christian-Alberts-Universität zu Kiel, 24118 Kiel, Germany
| | - T Martin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Martínez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - N Masi
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - D Maurin
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - A Menchaca-Rocha
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, 01000 Mexico
| | - Q Meng
- Southeast University (SEU), Nanjing, 210096, China
| | - V V Mikhailov
- NRNU MEPhI (Moscow Engineering Physics Institute), Moscow, 115409 Russia
| | - D C Mo
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - M Molero
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - P Mott
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - L Mussolin
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - J Negrete
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - N Nikonov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - F Nozzoli
- INFN TIFPA, 38123 Povo, Trento, Italy
| | - A Oliva
- INFN Sezione di Bologna, 40126 Bologna, Italy
| | - M Orcinha
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1649-003 Lisboa, Portugal
| | - M Palermo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Palmonari
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - M Paniccia
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - A Pashnin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Pauluzzi
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - S Pensotti
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - H D Phan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - R Piandani
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
| | - V Plyaskin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - S Poluianov
- Sodankylä Geophysical Observatory and Space Physics and Astronomy Research Unit, University of Oulu, 90014 Oulu, Finland
| | - X Qin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Z Y Qu
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - L Quadrani
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - P G Rancoita
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
| | - D Rapin
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - A Reina Conde
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - E Robyn
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - S Rosier-Lees
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - A Rozhkov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - D Rozza
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - R Sagdeev
- East-West Center for Space Science, University of Maryland, College Park, Maryland 20742, USA
| | - S Schael
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - A Schulz von Dratzig
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - G Schwering
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - E S Seo
- IPST, University of Maryland, College Park, Maryland 20742, USA
| | - Z Shakfa
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - B S Shan
- Beihang University (BUAA), Beijing, 100191, China
| | - T Siedenburg
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Solano
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J W Song
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - X J Song
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - R Sonnabend
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - L Strigari
- INFN Sezione di Roma 1, 00185 Roma, Italy
| | - T Su
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - Q Sun
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Z T Sun
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - M Tacconi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - X W Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - Z C Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - J Tian
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - Samuel C C Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - S M Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - N Tomassetti
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - J Torsti
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - C Tüysüz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - T Urban
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - I Usoskin
- Sodankylä Geophysical Observatory and Space Physics and Astronomy Research Unit, University of Oulu, 90014 Oulu, Finland
| | - V Vagelli
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Agenzia Spaziale Italiana (ASI), 00133 Roma, Italy
| | - R Vainio
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - M Valencia-Otero
- Physics Department and Center for High Energy and High Field Physics, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - E Valente
- INFN Sezione di Roma 1, 00185 Roma, Italy
- Università di Roma La Sapienza, 00185 Roma, Italy
| | - E Valtonen
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - M Vázquez Acosta
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - M Vecchi
- Kapteyn Astronomical Institute, University of Groningen, P.O. Box 800, 9700 AV Groningen, Netherlands
| | - M Velasco
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J P Vialle
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - C X Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - L Wang
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing, 100190, China
| | - L Q Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - N H Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Q L Wang
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing, 100190, China
| | - S Wang
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - X Wang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Yu Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Z M Wang
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - J Wei
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - Z L Weng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Wu
- Southeast University (SEU), Nanjing, 210096, China
| | - R Q Xiong
- Southeast University (SEU), Nanjing, 210096, China
| | - W Xu
- Shandong University (SDU), Jinan, Shandong, 250100, China
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - Q Yan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y Yang
- National Cheng Kung University, Tainan, 70101, Taiwan
| | - I I Yashin
- NRNU MEPhI (Moscow Engineering Physics Institute), Moscow, 115409 Russia
| | - H Yi
- Southeast University (SEU), Nanjing, 210096, China
| | - Y M Yu
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - Z Q Yu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - M Zannoni
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - C Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - F Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - F Z Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - J H Zhang
- Southeast University (SEU), Nanjing, 210096, China
| | - Z Zhang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - F Zhao
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - C Zheng
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - Z M Zheng
- Beihang University (BUAA), Beijing, 100191, China
| | - H L Zhuang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - V Zhukov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - A Zichichi
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - P Zuccon
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| |
Collapse
|
208
|
Abstract
BACKGROUND To assess any correlation of plasma hepatocyte growth factor (HGF) levels with relevant endothelial cell injury parameters and determine the prognostic value in septic patients. METHODS A prospective, observational study was conducted in patients with sepsis admitted to the Department of Critical Care Medicine at the Zhongda Hospital from November 2017 to March 2018. Plasma HGF levels were measured by enzyme-linked immunosorbent assay in the first 24 h after admission (day 1) and on day 3. The primary endpoint was defined as all-cause 28-day mortality. Furthermore, we analyzed the correlation of HGF with relevant endothelial cell injury markers. RESULTS Eighty-six patients admitted with sepsis were included. HGF levels of nonsurvivors were elevated compared to those of survivors on day 1 (1940.62 ± 74.66 pg/mL vs. 1635.61 ± 47.49 pg/mL; P = 0.002) and day 3 (1824.82 ± 137.52 pg/mL vs. 1309.77 ± 83.49 pg/mL; P = 0.001) and showed a strong correlation with von Willebrand factor (r = 0.45, P < 0.0001), lactate (r = 0.35, P = 0.0011), pulmonary vascular permeability index (r = 0.38, P = 0.0241), first 24 h fluid administration (r = 0.38, P < 0.0001), and sequential organ failure assessment score (r = 0.40, P = 0.0001). Plasma HGF levels were able to prognostically discriminate between survivors and nonsurvivors on day 1 (AUC: 0.72, 95%CI: 0.60-0.84) and day 3 (AUC: 0.77, 95%CI: 0.63-0.91). CONCLUSIONS HGF levels are associated with sepsis and correlated with established markers of endothelial cell injury. Elevated HGF levels in sepsis patients are an efficient indicator of poor prognosis. TRIAL REGISTRATION The study was registered in Clinical Trial (Registration Number: NCT02883231).
Collapse
Affiliation(s)
- Fei Peng
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Chenglong Liang
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Wei Chang
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Qin Sun
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Jianfeng Xie
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Haibo Qiu
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| | - Yi Yang
- Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China
| |
Collapse
|
209
|
Shen SJ, Xu YL, Zhou YD, Ren GS, Jiang J, Jiang HC, Zhang J, Li B, Jin F, Li YP, Xie FM, Shi Y, Wang ZD, Sun M, Yuan SH, Yu JJ, Chen Y, Sun Q. [A comparative study of breast cancer mass screening and opportunistic screening in Chinese women]. Zhonghua Wai Ke Za Zhi 2021; 59:109-115. [PMID: 33378802 DOI: 10.3760/cma.j.cn112139-20201015-00753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To compare the population characteristics, the positive rate of screening, the detection rate of breast cancer, early diagnosis rate and the cost between the mass screening group and opportunistic screening group of breast cancer. Methods: This study is a prospective multicenter cohort study conducted from January 1, 2014 to December 31, 2016. The participants were enrolled for mass screening or opportunistic screening of breast cancer. After completing the questionnaire, all the participants received breast physical examination and breast ultrasound examination every year for 3 rounds by year. The participants' characteristics and screening results of the two groups were compared by χ2 test, Fisher exact test or Wilcoxon rank-sum test. Results: A total of 20 080 subjects were enrolled. In the mass screening group, 9 434 (100%), 8 111 (85.98%) and 3 940 (41.76%) cases completed the 3 rounds of screening, and 10 646 (100%), 6 209 (58.32%) and 2 988 (28.07%) cases in the opportunistic screening group, respectively. In the opportunistic screening group, the proportions of less than 3 months lactation (1 275/9 796 vs. 1 061/8 860, χ²=4.597, P=0.032), non-fertility (850/10 646 vs. 574/9 434, χ²=27.400, P<0.01), abortion history (6 384/10 646 vs. 5 062/9 434, χ²=81.232, P<0.01), postmenopausal (2 776/10 646 vs. 2 217/9 434, χ²=17.757, P<0.01), long-term oral contraceptives(>6 months) (171/10 646 vs. 77/9 434, χ²=25.593, P<0.01) and family history of breast cancer in first-degree relatives (464/10 646 vs. 236/9 434, χ²=51.257, P<0.01) were significantly higher than those in mass screening group. The positive rate of screening (514/10 646 vs. 128/9 434, χ²=194.736, P<0.01), the detection rate of breast cancer (158/10 646 vs. 13/9 434, χ²=107.374, P<0.01), and positive rate of biopsy (158/452 vs. 13/87, χ²=13.491, P<0.01) in the opportunistic screening group were significantly higher than those of the mass screening group. The early diagnosis rate of the mass screening group was significantly higher than the opportunistic screening group (10/12 vs. 66/141, χ²=5.902, P=0.015). The average cost for detecting each breast cancer case of the mass screening group was 215 038 CNY, which was 13.6 times of the opportunistic screening group (15 799 CNY/case). In the opportunistic screening group, the positive rate of biopsy in primary hospitals was significantly lower than that in large-volume hospitals (79/267 vs. 79/185, χ²=8.267, P=0.004), but there was no significant difference in the mass screening group (6/37 vs. 7/50, χ²=0.082, P=0.774). Conclusions: Breast cancer screening can improve early detection rate. Compared with the mass screening mode, the opportunistic screening mode has the advantages of higher proportion of high-risk factors, higher positive rate of screening, higher detection rate of breast cancer, higher positive rate of biopsy, and lower cost of screening. However, the early diagnosis rate of breast cancer of opportunistic screening is lower than that of mass screening. The positive rate of opportunistic screening in primary hospitals is lower than that of large-volume hospitals. The two screening modes have their own advantages and should be chosen according to local conditions of different regions in China.
Collapse
Affiliation(s)
- S J Shen
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Y L Xu
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Y D Zhou
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - G S Ren
- Department of Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - J Jiang
- Department of Breast Surgery, the Southwest Hospital of Army Medical University, Chongqing 400038, China
| | - H C Jiang
- Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - J Zhang
- Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - B Li
- Department of Breast Surgery, Beijing Hospital, Beijing 100005, China
| | - F Jin
- Department of Breast Surgery, the First Affiliated Hospital of China Medical University, Shenyang 110001, China
| | - Y P Li
- Department of General Surgery, Chifeng Baoshan Hospital, Chifeng 024076, Inner Mongolia Autonomous Region, China
| | - F M Xie
- Department of General Surgery, the First People's Hospital of Hani-Yi Autonomous Prefecture of Honghe, Mengzi 661100, Yunnan Province, China
| | - Y Shi
- Department of Breast, Shanxi Institute of Traditional Chinese Medicine, Taiyuan 030012, China
| | - Z D Wang
- Department of General Surgery, Ordos Central Hospital, Ordos 017299, Inner Mongolia Autonomous Region, China
| | - M Sun
- Department of Breast Surgery, Qingdao Municipal Hospital, Qingdao 266011, China
| | - S H Yuan
- Department of Breast Surgery, Hospital of Xinjiang Production and Construction Corps, Urumqi 830002, China
| | - J J Yu
- Department of Breast Surgery, Xingtai Third Hospital, Xingtai 054000, Hebei Province, China
| | - Y Chen
- Hubei Yingshan Maternal and Child Health Care Hospital, Huanggang 438700, Hubei Province, China
| | - Q Sun
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| |
Collapse
|
210
|
Sun Q, Liu Q, Di R, Wang Y, Gan S, Liu S, Wang X, Hu W, Cao X, Pan Z, Guo X, Yang Y, Rushdi H, Chu M. Polymorphism and Comparative Expression Analysis of THRSP Gene in Fat-Tailed and Thin-Tailed Sheep Breeds. PAK J ZOOL 2021. [DOI: 10.17582/journal.pjz/20190822070832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
211
|
Aguilar M, Cavasonza LA, Allen MS, Alpat B, Ambrosi G, Arruda L, Attig N, Barao F, Barrin L, Bartoloni A, Başeğmez-du Pree S, Battiston R, Behlmann M, Beischer B, Berdugo J, Bertucci B, Bindi V, de Boer W, Bollweg K, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Burmeister S, Cai XD, Capell M, Casaus J, Castellini G, Cervelli F, Chang YH, Chen GM, Chen GR, Chen HS, Chen Y, Cheng L, Chou HY, Chouridou S, Choutko V, Chung CH, Clark C, Coignet G, Consolandi C, Contin A, Corti C, Cui Z, Dadzie K, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Di Felice V, Díaz C, Dimiccoli F, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Feng J, Fiandrini E, Fisher P, Formato V, Freeman C, Galaktionov Y, Gámez C, García-López RJ, Gargiulo C, Gast H, Gervasi M, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Haino S, Han KC, Hashmani RK, He ZH, Heber B, Hsieh TH, Hu JY, Incagli M, Jang WY, Jia Y, Jinchi H, Kanishev K, Khiali B, Kim GN, Kirn T, Konyushikhin M, Kounina O, Kounine A, Koutsenko V, Kuhlman A, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Li JQ, Li M, Li Q, Li S, Li JH, Li ZH, Liang J, Light C, Lin CH, Lippert T, Liu JH, Liu Z, Lu SQ, Lu YS, Luebelsmeyer K, Luo JZ, Luo X, Lyu SS, Machate F, Mañá C, Marín J, Marquardt J, Martin T, Martínez G, Masi N, Maurin D, Menchaca-Rocha A, Meng Q, Mikhailov VV, Mo DC, Molero M, Mott P, Mussolin L, Negrete J, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Paniccia M, Pashnin A, Pauluzzi M, Pensotti S, Phan HD, Piandani R, Plyaskin V, Poluianov S, Qin X, Qu ZY, Quadrani L, Rancoita PG, Rapin D, Conde AR, Robyn E, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Schael S, von Dratzig AS, Schwering G, Seo ES, Shakfa Z, Shan BS, Siedenburg T, Solano C, Song JW, Song XJ, Sonnabend R, Strigari L, Su T, Sun Q, Sun ZT, Tacconi M, Tang XW, Tang ZC, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Tüysüz C, Urban T, Usoskin I, Vagelli V, Vainio R, Valencia-Otero M, Valente E, Valtonen E, Vázquez Acosta M, Vecchi M, Velasco M, Vialle JP, Wang CX, Wang L, Wang LQ, Wang NH, Wang QL, Wang S, Wang X, Wang Y, Wang ZM, Wei J, Weng ZL, Wu H, Xiong RQ, Xu W, Yan Q, Yang Y, Yashin II, Yi H, Yu YM, Yu ZQ, Zannoni M, Zhang C, Zhang F, Zhang FZ, Zhang JH, Zhang Z, Zhao F, Zheng C, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zimmermann N, Zuccon P. Properties of Iron Primary Cosmic Rays: Results from the Alpha Magnetic Spectrometer. Phys Rev Lett 2021; 126:041104. [PMID: 33576661 DOI: 10.1103/physrevlett.126.041104] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2020] [Revised: 11/22/2020] [Accepted: 12/09/2020] [Indexed: 06/12/2023]
Abstract
We report the observation of new properties of primary iron (Fe) cosmic rays in the rigidity range 2.65 GV to 3.0 TV with 0.62×10^{6} iron nuclei collected by the Alpha Magnetic Spectrometer experiment on the International Space Station. Above 80.5 GV the rigidity dependence of the cosmic ray Fe flux is identical to the rigidity dependence of the primary cosmic ray He, C, and O fluxes, with the Fe/O flux ratio being constant at 0.155±0.006. This shows that unexpectedly Fe and He, C, and O belong to the same class of primary cosmic rays which is different from the primary cosmic rays Ne, Mg, and Si class.
Collapse
Affiliation(s)
- M Aguilar
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - L Ali Cavasonza
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - M S Allen
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - B Alpat
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - G Ambrosi
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - L Arruda
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1649-003 Lisboa, Portugal
| | - N Attig
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, 52425 Jülich, Germany
| | - F Barao
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1649-003 Lisboa, Portugal
| | - L Barrin
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | | | - S Başeğmez-du Pree
- Kapteyn Astronomical Institute, University of Groningen, P.O. Box 800, 9700 AV Groningen, Netherlands
| | - R Battiston
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| | - M Behlmann
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - B Beischer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - J Berdugo
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - B Bertucci
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - V Bindi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - W de Boer
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
| | - K Bollweg
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - B Borgia
- INFN Sezione di Roma 1, 00185 Roma, Italy
- Università di Roma La Sapienza, 00185 Roma, Italy
| | - M J Boschini
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
| | - M Bourquin
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - E F Bueno
- Kapteyn Astronomical Institute, University of Groningen, P.O. Box 800, 9700 AV Groningen, Netherlands
| | - J Burger
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | | | - S Burmeister
- Institut für Experimentelle und Angewandte Physik, Christian-Alberts-Universität zu Kiel, 24118 Kiel, Germany
| | - X D Cai
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Capell
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J Casaus
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | | | - Y H Chang
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
- Physics Department and Center for High Energy and High Field Physics, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - G M Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - G R Chen
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - H S Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - Y Chen
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - L Cheng
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - H Y Chou
- Physics Department and Center for High Energy and High Field Physics, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - S Chouridou
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - V Choutko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C H Chung
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Clark
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Coignet
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - C Consolandi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Contin
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - C Corti
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - Z Cui
- Shandong University (SDU), Jinan, Shandong, 250100, China
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - K Dadzie
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C Delgado
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | - M B Demirköz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - L Derome
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | | | - V Di Felice
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - C Díaz
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | - P von Doetinchem
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Dong
- Southeast University (SEU), Nanjing, 210096, China
| | - F Donnini
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - M Duranti
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - A Egorov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Eline
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J Feng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - E Fiandrini
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - P Fisher
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Formato
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - C Freeman
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - Y Galaktionov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C Gámez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - R J García-López
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - C Gargiulo
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - H Gast
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - M Gervasi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - F Giovacchini
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - D M Gómez-Coral
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - J Gong
- Southeast University (SEU), Nanjing, 210096, China
| | - C Goy
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - V Grabski
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, 01000 Mexico
| | - D Grandi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - M Graziani
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - S Haino
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - K C Han
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan, 32546, Taiwan
| | - R K Hashmani
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - Z H He
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - B Heber
- Institut für Experimentelle und Angewandte Physik, Christian-Alberts-Universität zu Kiel, 24118 Kiel, Germany
| | - T H Hsieh
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J Y Hu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - M Incagli
- INFN Sezione di Pisa, 56100 Pisa, Italy
| | - W Y Jang
- CHEP, Kyungpook National University, 41566 Daegu, Korea
| | - Yi Jia
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Jinchi
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan, 32546, Taiwan
| | | | - B Khiali
- INFN Sezione di Roma Tor Vergata, 00133 Roma, Italy
| | - G N Kim
- CHEP, Kyungpook National University, 41566 Daegu, Korea
| | - Th Kirn
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - M Konyushikhin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - O Kounina
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kounine
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Koutsenko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kuhlman
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Kulemzin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - G La Vacca
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - E Laudi
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - G Laurenti
- INFN Sezione di Bologna, 40126 Bologna, Italy
| | - I Lazzizzera
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| | - A Lebedev
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H T Lee
- Academia Sinica Grid Center (ASGC), Nankang, Taipei, 11529, Taiwan
| | - S C Lee
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - J Q Li
- Southeast University (SEU), Nanjing, 210096, China
| | - M Li
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - Q Li
- Southeast University (SEU), Nanjing, 210096, China
| | - S Li
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - J H Li
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Z H Li
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - J Liang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - C Light
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C H Lin
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - T Lippert
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, 52425 Jülich, Germany
| | - J H Liu
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing, 100190, China
| | - Z Liu
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - S Q Lu
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - Y S Lu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - K Luebelsmeyer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - J Z Luo
- Southeast University (SEU), Nanjing, 210096, China
| | - Xi Luo
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - S S Lyu
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - F Machate
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Mañá
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J Marín
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J Marquardt
- Institut für Experimentelle und Angewandte Physik, Christian-Alberts-Universität zu Kiel, 24118 Kiel, Germany
| | - T Martin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Martínez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - N Masi
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - D Maurin
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - A Menchaca-Rocha
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, 01000 Mexico
| | - Q Meng
- Southeast University (SEU), Nanjing, 210096, China
| | - V V Mikhailov
- NRNU MEPhI (Moscow Engineering Physics Institute), Moscow, 115409 Russia
| | - D C Mo
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - M Molero
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - P Mott
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - L Mussolin
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - J Negrete
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - N Nikonov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - F Nozzoli
- INFN TIFPA, 38123 Povo, Trento, Italy
| | - A Oliva
- INFN Sezione di Bologna, 40126 Bologna, Italy
| | - M Orcinha
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1649-003 Lisboa, Portugal
| | - M Palermo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Palmonari
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - M Paniccia
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - A Pashnin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Pauluzzi
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - S Pensotti
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - H D Phan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - R Piandani
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
| | - V Plyaskin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - S Poluianov
- Sodankylä Geophysical Observatory and Space Physics and Astronomy Research Unit, University of Oulu, 90014 Oulu, Finland
| | - X Qin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Z Y Qu
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - L Quadrani
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - P G Rancoita
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
| | - D Rapin
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - A Reina Conde
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - E Robyn
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - S Rosier-Lees
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - A Rozhkov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - D Rozza
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - R Sagdeev
- East-West Center for Space Science, University of Maryland, College Park, Maryland 20742, USA
| | - S Schael
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - A Schulz von Dratzig
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - G Schwering
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - E S Seo
- IPST, University of Maryland, College Park, Maryland 20742, USA
| | - Z Shakfa
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - B S Shan
- Beihang University (BUAA), Beijing, 100191, China
| | - T Siedenburg
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Solano
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J W Song
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - X J Song
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - R Sonnabend
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - L Strigari
- INFN Sezione di Roma 1, 00185 Roma, Italy
| | - T Su
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - Q Sun
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Z T Sun
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - M Tacconi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - X W Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - Z C Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - J Tian
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - Samuel C C Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - S M Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - N Tomassetti
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - J Torsti
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - C Tüysüz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - T Urban
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - I Usoskin
- Sodankylä Geophysical Observatory and Space Physics and Astronomy Research Unit, University of Oulu, 90014 Oulu, Finland
| | - V Vagelli
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Agenzia Spaziale Italiana (ASI), 00133 Roma, Italy
| | - R Vainio
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - M Valencia-Otero
- Physics Department and Center for High Energy and High Field Physics, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - E Valente
- INFN Sezione di Roma 1, 00185 Roma, Italy
- Università di Roma La Sapienza, 00185 Roma, Italy
| | - E Valtonen
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - M Vázquez Acosta
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - M Vecchi
- Kapteyn Astronomical Institute, University of Groningen, P.O. Box 800, 9700 AV Groningen, Netherlands
| | - M Velasco
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J P Vialle
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - C X Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - L Wang
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing, 100190, China
| | - L Q Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - N H Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Q L Wang
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing, 100190, China
| | - S Wang
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - X Wang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Yu Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Z M Wang
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - J Wei
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - Z L Weng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Wu
- Southeast University (SEU), Nanjing, 210096, China
| | - R Q Xiong
- Southeast University (SEU), Nanjing, 210096, China
| | - W Xu
- Shandong University (SDU), Jinan, Shandong, 250100, China
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - Q Yan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y Yang
- National Cheng Kung University, Tainan, 70101, Taiwan
| | - I I Yashin
- NRNU MEPhI (Moscow Engineering Physics Institute), Moscow, 115409 Russia
| | - H Yi
- Southeast University (SEU), Nanjing, 210096, China
| | - Y M Yu
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - Z Q Yu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - M Zannoni
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - C Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - F Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - F Z Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - J H Zhang
- Southeast University (SEU), Nanjing, 210096, China
| | - Z Zhang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - F Zhao
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing, 100049, China
| | - C Zheng
- Shandong Institute of Advanced Technology (SDIAT), Jinan, Shandong, 250100, China
| | - Z M Zheng
- Beihang University (BUAA), Beijing, 100191, China
| | - H L Zhuang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing, 100049, China
| | - V Zhukov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - A Zichichi
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - N Zimmermann
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - P Zuccon
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| |
Collapse
|
212
|
Ren W, Ma Y, Wang R, Liang P, Sun Q, Pu Q, Dong L, Mazhar M, Luo G, Yang S. Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application. Front Pharmacol 2021; 11:589714. [PMID: 33584265 PMCID: PMC7873690 DOI: 10.3389/fphar.2020.589714] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Accepted: 11/10/2020] [Indexed: 01/08/2023] Open
Abstract
Since the sudden epidemic of coronavirus disease 2019 (COVID-19), the State Administration of Traditional Chinese Medicine immediately organized experts to formulate and screen the effective prescriptions of traditional Chinese medicine according to the characteristics of the novel coronavirus infection. Qingfei Paidu decoction (QFPDD) has been proven to be effective in multi-provincial clinical trials, and has been selected as a general prescription for the treatment of COVID-19 in different stages that was later promoted to be used nationwide. This review highlights the latest advances of QFPDD, focusing on the TCM theory, mechanism analysis, clinical application of QFPDD and its future perspectives. Moreover, an in-depth discussion of some valuable issues and possible development for future research on QFPDD is also discussed, aiming to provide a novel guide to combat the global epidemic COVID-19.
Collapse
Affiliation(s)
- Wei Ren
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.,Faculty of Integrative Medicine, Southwest Medical University, Luzhou, China
| | - Yue Ma
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Raoqiong Wang
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Pan Liang
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Qin Sun
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.,Faculty of Integrative Medicine, Southwest Medical University, Luzhou, China
| | - Qingrong Pu
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Li Dong
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Maryam Mazhar
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.,Faculty of Integrative Medicine, Southwest Medical University, Luzhou, China
| | - Gang Luo
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Sijin Yang
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.,Faculty of Integrative Medicine, Southwest Medical University, Luzhou, China
| |
Collapse
|
213
|
Patel RV, Thikkurissy S, Schwartz SB, Gosnell ES, Sun Q, Cully JL. Preferential Use of Stainless Steel Crowns as a Strategy to Minimize Retreatment of Primary Molars under General Anesthesia. Pediatr Dent 2021; 43:24-27. [PMID: 33662246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Purpose: The purpose of this study was to investigate whether primary molars treated with composite resins (CRs) and stainless steel crowns (SSCs) during an oral rehabilitation under general anesthesia (GA1) required retreatment at a second oral rehabilitation under GA (GA2). Methods: Records were examined from 296 healthy patients with more than one dental rehabilitation under general anesthesia from June 2012 to January 2019. Data included treatment details and demographic information. Frequencies and means were recorded. An analysis was completed using logistic regression and chi-square for categorical variables. Results: For primary first molars, 43 percent of CRs placed at GA1 were treated with SSCs at GA2. For primary second molars, 35 percent of CRs placed at GA1 were treated with SSCs at GA2. There was no statistically significant difference in retreatment rates by molar type (P equals 0.27). Eight percent of SSCs placed on any molar at GA1 required retreatment at GA2. Conclusions: Primary molars treated with stainless steel crowns using general anesthesia had the lowest percentage of retreatment compared to those treated with composite resins. Strong consideration should be given to the placement of SSCs on primary molars in patients with early childhood caries under general anesthesia. Placement of primary molar SSCs during initial treatment under general anesthesia may reduce the need for additional treatment in the future.
Collapse
Affiliation(s)
| | - S Thikkurissy
- Dr. Thikkurissy is a professor, and a professor and Robert Creedon chair, Cincinnati, Ohio
| | | | | | - Qin Sun
- Ms. Sun is a biostatistician, Cincinnati, Ohio
| | | |
Collapse
|
214
|
Sun Q, Shi L, Yao J, Wang WJ. [Experience of laparoscopic surgery in patients with new colorectal cancer after liver transplantation]. Zhonghua Wei Chang Wai Ke Za Zhi 2021; 23:1214-1216. [PMID: 33353281 DOI: 10.3760/cma.j.cn.441530-20190514-00211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
215
|
Li C, Wu D, Li J, Ji X, Qi L, Sun Q, Wang A, Xie C, Gong J, Chen W. Multicomponent crystals of clotrimazole: a combined theoretical and experimental study. CrystEngComm 2021. [DOI: 10.1039/d1ce00934f] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Compared with clotrimazole, some multicomponent crystals showed an improvement in solubility and dissolution rate.
Collapse
Affiliation(s)
- Chang Li
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
| | - Di Wu
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
| | - Jiulong Li
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
| | - Xu Ji
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
| | - Luguang Qi
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
| | - Qin Sun
- Shenyang Sinochem Agrochemicals R&D Co., Ltd, Shenyang, Liaoning, 110021 P. R. China
| | - Aiyu Wang
- Shandong Lukang Pharmaceutical Co., Ltd, Jining, Shandong, 272104, P. R. China
| | - Chuang Xie
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
- Collaborative Innovation Center of Chemical Science and Engineering, Tianjin 300072, P. R. China
| | - Junbo Gong
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
- Collaborative Innovation Center of Chemical Science and Engineering, Tianjin 300072, P. R. China
| | - Wei Chen
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, P. R. China
- Collaborative Innovation Center of Chemical Science and Engineering, Tianjin 300072, P. R. China
| |
Collapse
|
216
|
Bhat S, Trieu K, Dai Z, Leander K, Gigante B, Qian F, Korat A, Sun Q, Pan X, Laguzzi F, Cederholm T, de Faire U, Hellénius M, Wu J, Risérus U, Marklund M. Biomarkers of Dairy Fat Intake, Incident Cardiovascular Disease, and All-Cause Mortality: A Systematic Review and Meta-analysis. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
217
|
Sun Q, Yamada T, Han Y, Takano T. Influence of salt stress on C 4 photosynthesis in Miscanthus sinensis Anderss. Plant Biol (Stuttg) 2021; 23:44-56. [PMID: 33030790 DOI: 10.1111/plb.13192] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Revised: 09/23/2020] [Accepted: 09/24/2020] [Indexed: 06/11/2023]
Abstract
Miscanthus sinensis Anderss. is a good candidate for C4 bioenergy crop development for marginal lands. As one of the characteristics of marginal lands, salinization is a major limitation to agricultural production. The present work aimed to investigate the possible factors involved in the tolerance of M. sinensis C4 photosynthesis to salinity stress. Seedlings of two accessions (salt-tolerant 'JM0119' and salt-sensitive 'JM0099') were subjected to 0 mm NaCl (control) or 250 mm NaCl (salt stress treatment) for 2 weeks. The chlorophyll content, parameters of photosynthesis and chlorophyll a fluorescence, activity of C4 enzymes and expression of C4 genes were measured. The results showed that photosynthesis rate, transpiration rate, chlorophyll content, PSII operating efficiency, coefficient of photochemical quenching, activity of phosphoenolpyruvate carboxylase (PEPC) and pyruvate, orthophosphate dikinase (PPDK) and gene expression of PEPC and PPDK under salinity were higher after long-term salinity exposure in 'JM0119' than in 'JM0099', while activity of NADP-malate dehydrogenase (NADP-MDH) and NADP-malic enzyme (NADP-ME), together with expression of NADP-MDH and NADP-ME, were much higher in 'JM0099' than in 'JM0119'. In conclusion, the increased photosynthetic capacity under long-term salt stress in the salt-tolerant relative to the salt-sensitive M. sinensis accession was mainly associated with non-stomatal factors, such as reduced chlorophyll loss, higher PSII operating efficiency, enhanced activity of PEPC and PPDK and relatively lower activity of NADP-ME.
Collapse
Affiliation(s)
- Q Sun
- Asian Natural Environmental Science Center (ANESC), The University of Tokyo, Tokyo, Japan
- College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, Guangdong, China
| | - T Yamada
- Field Science Center for Northern Biosphere, Hokkaido University, Sapporo, Hokkaido, Japan
| | - Y Han
- College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, Guangdong, China
| | - T Takano
- Asian Natural Environmental Science Center (ANESC), The University of Tokyo, Tokyo, Japan
| |
Collapse
|
218
|
Orkin S, Yodoshi T, Sun Q, Fei L, Meryum S, Arce-Clachar AC, Bramlage K, Beck AF, Mouzaki M. Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease? Obesity (Silver Spring) 2021; 29:171-176. [PMID: 33185977 PMCID: PMC7902314 DOI: 10.1002/oby.22999] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Revised: 07/13/2020] [Accepted: 07/31/2020] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Longitudinal studies on childhood predictors of nonalcoholic fatty liver disease (NAFLD) progression are lacking. The objective of this study was to determine whether baseline clinical or laboratory measures predict liver disease outcomes in a pediatric NAFLD cohort. METHODS A retrospective study of patients with presumed NAFLD was conducted using baseline and follow-up clinical and laboratory measures. Disease outcomes were defined using the mean serum alanine aminotransferase (ALT) levels from 24 to 36 months after the first visit. Logistic regression assessed the relationship between ALT progression/regression and predictor variables. Multivariable regression determined the best model for predicting the ALT outcome. Markov process modeling explored the likelihood for a patient to transition between ALT states. RESULTS Of a total of 816 patients identified, 144 had sufficient data. Regression was seen in 26%, whereas 30% progressed. No baseline clinical or laboratory measurements had a significant effect on disease outcomes. Markov modeling demonstrated that subjects were more likely to either remain in their baseline ALT group or worsen rather than improve. CONCLUSIONS Routinely obtained baseline clinical or laboratory measures cannot help risk-stratify youth with presumed NAFLD in terms of long-term outcomes. Close clinical, radiographic, and histologic evaluation of patients is warranted to determine those at risk of progression.
Collapse
Affiliation(s)
- Sarah Orkin
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center
| | - Toshifumi Yodoshi
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center
| | - Qin Sun
- Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center
| | - Lin Fei
- Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center
- Department of Pediatrics, University of Cincinnati College of Medicine
| | - Syeda Meryum
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center
| | - Ana Catalina Arce-Clachar
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center
- Department of Pediatrics, University of Cincinnati College of Medicine
| | - Kristin Bramlage
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center
| | - Andrew F. Beck
- Department of Pediatrics, University of Cincinnati College of Medicine
- James M. Anderson Center for Health Systems Excellence, Cincinnati Children’s Hospital Medical Center
- Division of General and Community Pediatrics, Cincinnati Children’s Hospital Medical Center
- Division of Hospital Medicine, Cincinnati Children’s Hospital Medical Center
| | - Marialena Mouzaki
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center
- Department of Pediatrics, University of Cincinnati College of Medicine
| |
Collapse
|
219
|
Cui Q, Liu D, Xiang B, Sun Q, Fan L, He M, Wang Y, Zhu X, Ye H. Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing's Disease. Int J Endocrinol 2021; 2021:4586229. [PMID: 34527048 PMCID: PMC8437621 DOI: 10.1155/2021/4586229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Accepted: 08/12/2021] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND The suppressed hypothalamic-pituitary-adrenal (HPA) axis after successful surgery for Cushing's disease (CD) will recover in almost all patients. We aimed to identify the predictive factors for HPA axis recovery in CD patients with postoperative remission. Design and Methods. This observational retrospective cross-sectional study enrolled 69 CD patients with postoperative remission in Huashan Hospital from 2015 to 2019. All subjects had a detailed clinical evaluation. The low-dose ACTH stimulation test (LDT) was conducted as the gold standard for assessing the HPA axis function. RESULTS Peak cortisol in LDT was found only to be positively correlative with morning serum cortisol (MSC) (ρ=0.451, p < 0.001). The MSC was higher (p < 0.001), and the median postoperative course was significantly longer (p=0.025) in the patients with the recovered HPA axis function compared with unrecovered patients. The AUC value of MSC for predicting the recovery of the HPA axis was 0.701, and the optimal cutoff was 6.25 μg/dl (sensitivity 85.19% and specificity 47.62%). Other useful cutoff values were 10.74 μg/dl (specificity 100%) and 4.18 μg/dl (sensitivity 100%). Besides, combined with the postoperative course, the AUC values were higher than MSC alone (0.935 vs. 0.701, p < 0.001). CONCLUSIONS MSC is a viable first-step diagnostic predictor for HPA axis recovery in CD patients with postoperative remission. For the patients with cortisol levels between 4.18 and 10.74 μg/dl, a confirmatory test should be conducted. When the MSC level was 10.74 μg/dl or greater, the replacement therapy could be discontinued.
Collapse
Affiliation(s)
- Q. Cui
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| | - D. Liu
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| | - B. Xiang
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| | - Q. Sun
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| | - L. Fan
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| | - M. He
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| | - Y. Wang
- Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China
| | - X. Zhu
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| | - H. Ye
- Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, China
| |
Collapse
|
220
|
Pan Z, Liu M, Zhao H, Tan Z, Liang K, Sun Q, Gong D, He H, Zhou W, Qiu F. ZmSRL5 is involved in drought tolerance by maintaining cuticular wax structure in maize. J Integr Plant Biol 2020; 62:1895-1909. [PMID: 32965083 DOI: 10.1111/jipb.12982] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Accepted: 06/10/2020] [Indexed: 05/20/2023]
Abstract
Cuticular wax is a natural barrier on terrestrial plant organs, which protects plants from damages caused by a variety of stresses. Here, we report the identification and functional characterization of a cuticular-wax-related gene, Zea mays L. SEMI-ROLLED LEAF 5 (ZmSRL5). The loss-of-function mutant srl5, which was created by a 3,745 bp insertion in the first intron that led to the premature transcript, exhibited abnormal wax crystal morphology and distribution, which, in turn, caused the pleiotropic phenotypes including increased chlorophyll leaching and water loss rate, decreased leaf temperature, sensitivity to drought, as well as semi-rolled mature leaves. However, total wax amounts showed no significant difference between wild type and semi-rolled leaf5 (srl5) mutant. The phenotype of srl5 was confirmed through the generation of two allelic mutants using CRISPR/Cas9. ZmSRL5 encodes a CASPARIAN-STRIP-MEMBRANE-DOMAIN-LIKE (CASPL) protein located in plasma membrane, and highly expressed in developing leaves. Further analysis showed that the expressions of the most wax related genes were not affected or slightly altered in srl5. This study, thus, primarily uncovers that ZmSRL5 is required for the structure formation of the cuticular wax and could increase the drought tolerance by maintaining the proper cuticular wax structure in maize.
Collapse
Affiliation(s)
- Zhenyuan Pan
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| | - Min Liu
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| | - Hailiang Zhao
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| | - Zengdong Tan
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| | - Kun Liang
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| | - Qin Sun
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| | - Dianming Gong
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| | - Haijun He
- Crop Research Institute, Gansu Academy of Agricultural Sciences, Lanzhou, 730070, China
| | - Wenqi Zhou
- Crop Research Institute, Gansu Academy of Agricultural Sciences, Lanzhou, 730070, China
| | - Fazhan Qiu
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan, 430070, China
| |
Collapse
|
221
|
Sun Q, Shen X, Ma J, Lou H, Sha W. LncRNA NEAT1 participates in inflammatory response in macrophages infected by mycobacterium tuberculosis through targeted regulation of miR-377-3p. Microb Pathog 2020; 150:104674. [PMID: 33271233 DOI: 10.1016/j.micpath.2020.104674] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Revised: 11/10/2020] [Accepted: 11/25/2020] [Indexed: 12/20/2022]
Abstract
Background Tuberculosis (TB) is a very serious public health problem in the world at present. The incidence rate is rising continuously. Once it develops to the middle and late stage, it can cause serious tissue damage and necrosis, directly threatening the life and health of patients. Because of its high incidence, high infectivity and high mortality, clinical research on TB has never stopped. Previous studies have confirmed the effect of macrophages on mycobacterium tuberculosis (MTB) infection, and its regulatory mechanism has not yet been fully clarified. Objective To analyze the effects of NEAT1 and miR-377-3p on macrophages infected by MTB and provide new reference for the diagnosis and treatment of TB in the future. Methods The pulmonary TB patients admitted to our hospital from July 2017 to July 2019 and the healthy cases at the same time were selected as the research objects for prospective analysis. In addition, THP-1 cells and mycobacterium tuberculosis H37Ra were purchased to construct macrophages infected by H37Ra, and the effects of NEAT1 and miR-377-3p on macrophages and their relationship with inflammatory factors were analyzed. Results NEAT1 was highly expressed in pulmonary TB patients and miR-377-3p was poorly expressed (p < 0.05). The concentrations of inflammatory factors in serum of patients with pulmonary TB were significantly higher than those in healthy cases (P < 0.001). After infection with H37Ra, the inflammatory factors in macrophages increased significantly (p < 0.001), while miR-377-3p decreased (p < 0.001). Inhibition of NEAT1 and increase of miR-377-3p could decrease inflammatory factors and proliferation ability of cells, and increase apoptosis rate (p < 0.001). The double luciferase reporter assay showed that the fluorescence activity of NEAT1-WT was inhibited by the transfection of miR-377-3pmimics (P < 0.001). Conclusion NEAT1 participates in inflammatory response in macrophages infected by MTB through targeted regulation of miR-377-3p.
Collapse
Affiliation(s)
- Qin Sun
- Shanghai Clinical Research Center for Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China
| | - Xiaona Shen
- Shanghai Clinical Research Center for Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China
| | - Jun Ma
- Shanghai Clinical Research Center for Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China
| | - Hai Lou
- Shanghai Clinical Research Center for Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China
| | - Wei Sha
- Shanghai Clinical Research Center for Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.
| |
Collapse
|
222
|
Sun Q, Huang Y, Hu ZQ. [Progression of pathogenesis, diagnosis and treatment of diversion colitis]. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23:1117-1122. [PMID: 33212566 DOI: 10.3760/cma.j.cn.441530-20191031-00468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Diversion colitis (DC) is a common non-specific inflammation of the malfunctioning bowel segment after diversion of feces. Although most patients develop DC during stoma, there are no obvious clinical symptoms, and a small number of patients show abdominal pain, mucus discharge and hematochezia. The erythema, diffuse particles and vascular texture blur are the most prominent endoscopic manifestations, and the lymphatic follicular hyperplasia is the most prominent pathological manifestations.Reconstruction of intestinal continuity is the best way to cure recanted colitis. In this review, we summarize and review the mechanism of occurrence, clinical features, diagnosis and treatment of DC, which will be helpful for the effective control and prevention of DC.
Collapse
Affiliation(s)
- Q Sun
- Department of General Surgery, Changzheng Hospital, the Navy Military Medical University, Shanghai 200003, China
| | - Y Huang
- Department of General Surgery, Changzheng Hospital, the Navy Military Medical University, Shanghai 200003, China
| | - Z Q Hu
- Department of General Surgery, Changzheng Hospital, the Navy Military Medical University, Shanghai 200003, China
| |
Collapse
|
223
|
Zheng L, Wang X, Zhou C, Liu Q, Li S, Sun Q, Wang M, Zhou Q, Wang W. Analysis of the Infection Status of Healthcare Workers in Wuhan During the COVID-19 Outbreak: A Cross-sectional Study. Clin Infect Dis 2020; 71:2109-2113. [PMID: 32409825 PMCID: PMC7239233 DOI: 10.1093/cid/ciaa588] [Citation(s) in RCA: 80] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2020] [Accepted: 05/12/2020] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Healthcare workers (HCWs) at the frontline are facing a substantial risk of infection during the coronavirus disease 2019 (COVID-19) outbreak. METHODS We acquired information and data on general information on and infection and death status of HCWs in Wuhan during the COVID-19 outbreak and completed statistical analyses. RESULTS We obtained the data on 2457 infected cases among HCWs in Wuhan, China. More than half of the infected individuals were nurses (52.06%), whereas 33.62% of infected cases were doctors and 14.33% of cases were medical staff. In particular, the case infection rate of nurses (2.22%) was remarkably higher than that of doctors (1.92%). Most infected cases among HCWs were female (72.28%). A majority of the infected HCWs (89.26%) came from general hospitals, followed by specialized hospitals (5.70%) and community hospitals (5.05%). The case infection rate of HCWs (2.10%) was dramatically higher than that of non-HCWs (0.43%). The case fatality rate of HCWs (0.69%) was significantly lower than that of non-HCWs (5.30%). CONCLUSIONS The infection risk of HCWs is clearly higher than that of non-HCWs. HCWs play an essential role in fighting the pandemic. The analysis of the infection status of HCWs is essential to attract enough attention from the public, provide effective suggestions for government agencies, and improve protective measures for HCWs.
Collapse
Affiliation(s)
- Lichun Zheng
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
| | - Xiang Wang
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
| | - Chongchong Zhou
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
| | - Qin Liu
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
| | - Shuang Li
- Department of Infectious Diseases, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - Qin Sun
- Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Mengjia Wang
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
| | - Qian Zhou
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
| | - Wenmei Wang
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China
| |
Collapse
|
224
|
Sun Q, Meng M, Steed JN, Sidow SJ, Bergeron BE, Niu LN, Ma JZ, Tay FR. Manoeuvrability and biocompatibility of endodontic tricalcium silicate-based putties. J Dent 2020; 104:103530. [PMID: 33220332 DOI: 10.1016/j.jdent.2020.103530] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Revised: 11/10/2020] [Accepted: 11/11/2020] [Indexed: 12/17/2022] Open
Abstract
OBJECTIVES The present study evaluated the indentation depth, storage modulus and biocompatibility of an experimental endodontic putty designed for endodontic perforation repair and direct pulp-capping (NeoPutty). The results were compared with the properties associated with the commercially available EndoSequence BC RRM Putty (ES Putty). METHODS Indentation depth was measured by a profilometer following indentation with the 1/4 lb Gilmore needle. Elastic modulus was evaluated using a strain-controlled rheometer. The effects of eluents derived from these two putties were examined on the viability and proliferation of human dental pulp stem cells (hDPSCs) and human periodontal ligament fibroblasts (hPDLFs), before (1 st testing cycle) and after complete setting (2nd testing cycle). RESULTS The ES Putty became more difficult to ident and acquired a larger storage modulus after exposure to atmospheric moisture. Biocompatibility results indicated that both putties were relatively more cytotoxic than the bioinert Teflon negative control, but much less cytotoxic than the zinc oxide-eugenol cement negative control. NeoPutty was less cytotoxic than ES putty in the 1st testing cycle, particularly with hDPSCs. Both putties exhibited more favourable cytotoxicity profiles after complete setting. CONCLUSIONS NeoPutty has a better window of maneuverability after exposure to atmospheric moisture. From an in vitro cytotoxicity perspective, the NeoPutty may be considered more biocompatible than ES putty. CLINICAL SIGNIFICANCE The experimental NeoPutty is biocompatible and is capable of reducing the frustration of shortened shelf life when jar-stored endodontic putties are exposed to atmospheric moisture during repeated opening of the lid for clinical retrieval.
Collapse
Affiliation(s)
- Qin Sun
- Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Meng Meng
- State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi, China
| | - Jeffrey N Steed
- Department of Endodontics, The Dental College of Georgia, Augusta University, Augusta, GA, USA
| | - Stephanie J Sidow
- Department of Endodontics, The Dental College of Georgia, Augusta University, Augusta, GA, USA
| | - Brian E Bergeron
- Department of Endodontics, The Dental College of Georgia, Augusta University, Augusta, GA, USA
| | - Li-Na Niu
- State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi, China.
| | - Jing-Zhi Ma
- Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
| | - Franklin R Tay
- Department of Endodontics, The Dental College of Georgia, Augusta University, Augusta, GA, USA.
| |
Collapse
|
225
|
Sun Q, Li Z, Lu W, Qiu J. Current Situation and Trend of Medical Imaging Graduates Working in the Field of Radiation Oncology - Based on Eleven Years’ Data from a Medical University in East China. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
226
|
Yan L, Sun Q, Liu Z, Wu M, Ge Y, Zhang Q. A new porous Co(II)‐coordination polymer for the chemical fixation of CO
2
and treatment effect against tuberculosis by reducing the
pckA
expression in
Mycobacterium tuberculosis
. Appl Organomet Chem 2020. [DOI: 10.1002/aoc.5908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Li‐Ping Yan
- Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China
| | - Qin Sun
- Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China
| | - Zhi‐Bin Liu
- Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China
| | - Min Wu
- Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China
| | - Yan‐Ping Ge
- Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China
| | - Qing Zhang
- Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China
| |
Collapse
|
227
|
Zhou H, Xu K, Sun Q, Wang Z, Ruan C. Three-port laparoscopic sigmoidectomy with natural orifice specimen extraction - a video vignette. Colorectal Dis 2020; 22:1782-1783. [PMID: 32533889 DOI: 10.1111/codi.15189] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2020] [Revised: 03/13/2020] [Accepted: 03/14/2020] [Indexed: 02/08/2023]
Affiliation(s)
- H Zhou
- Division of Colorectal Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China
| | - K Xu
- Division of Colorectal Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China
| | - Q Sun
- Division of Colorectal Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China
| | - Z Wang
- Division of Colorectal Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China
| | - C Ruan
- Division of Colorectal Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China
| |
Collapse
|
228
|
Tang W, Lu HY, Sun Q, Xu WM. [Effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates: a prospective randomized controlled trial]. Zhongguo Dang Dai Er Ke Za Zhi 2020; 22:1149-1153. [PMID: 33172546 PMCID: PMC7666384 DOI: 10.7499/j.issn.1008-8830.2007062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Accepted: 09/21/2020] [Indexed: 06/11/2023]
Abstract
OBJECTIVE To study the effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates. METHODS The neonates with hyperbilirubinemia who were hospitalized from January to December 2018 were enrolled and randomly divided into an observation group (n=61) and a control group (n=63). The neonates in the observation group were treated with phototherapy combined with Saccharomyces boulardii, and those in the control group were treated with phototherapy combined with placebo. Treatment outcomes were compared between the two groups. Fecal samples were collected 72 hours after treatment and 16s rRNA high-throughput sequencing was used to compare the features of gut microbiota between the two groups. RESULTS There was no significant difference in the total serum bilirubin level between the two groups before treatment (P>0.05). At 24, 48, and 72 hours after treatment, the observation group had a significantly lower level of total serum bilirubin than the control group (P<0.05). Compared with the control group, the observation group had a significantly lower proportion of neonates requiring phototherapy again [20% (12/61) vs 75% (47/63), P<0.05]. Compared with the control group, the observation group had a significantly higher abundance of Bacteroides (P<0.05) and a significantly lower abundance of Escherichia coli and Staphylococcus in the intestine at 72 hours after treatment (P<0.05). CONCLUSIONS In neonates with hyperbilirubinemia, phototherapy combined with Saccharomyces boulardii can effectively reduce bilirubin level and prevent the recurrence of jaundice. Saccharomyces boulardii can favour the treatment outcome by regulating the gut microbiota of neonates.
Collapse
Affiliation(s)
- Wei Tang
- Department of Pediatrics, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212000, China.
| | | | | | | |
Collapse
|
229
|
Yang YQ, Sun Q, Li CM, Chen HF, Zhao F, Huang JH, Zhou JS, Li XM, Lan B. Biological Characteristics and Genetic Diversity of Phomopsis asparagi, Causal Agent of Asparagus Stem Blight. Plant Dis 2020; 104:2898-2904. [PMID: 33006915 DOI: 10.1094/pdis-07-19-1484-re] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Asparagus stem blight is a regional disease. In the present study, we compared strains of Phomopsis asparagi from six different provinces to determine their biological characteristics and genetic diversity, differences in the pycnidium and conidium production, pathogenicity, and growth rate. Considerable differences were established in the pycnidium and conidium production among the P. asparagi strains from the six studied provinces. The largest pycnidium and conidium production had the strains from Fujian, followed by those from Hainan. The virulence of P. asparagi strains was significantly different but without a correlation with the geographical source of the strain. FJ2 had the highest virulence, followed by HN2, SD4, and SD5, whereas SD5 had the lowest virulence. The colony diameter and dry weight of the strains of asparagus stem blight fungus from the six provinces were substantially different. The colonies of HN1-5 had the largest diameters, whereas those of XT1-5, LT1-3, FJ1-5, and SX6 had smaller diameters. Four primers with good repeatability and strong specificity were selected from 100 intersimple sequence repeat (ISSR) primers. ISSR-PCR amplification was performed on 36 strains of asparagus stem blight fungus, and a large number of repeatable DNA fingerprints were obtained. Most of the amplified fragments were within 300 to 500 bp. In all, 69 total points, 64 multiple points, and 92.75% polymorphism points were established. The number of ISSR gene sites detected by four primers ranged from 14 to 20, with an average of 16 multiple sites. The copolymerization was divided into three groups: XT1-5, LT1-3, and FJ1-5, which were clustered into the first group; SD1-6, SX1-6, and HB1-6, clustered into the second group; and HN1-5 in the third group. The results of the cluster analysis revealed that the strains of the neighboring provinces had a nearer phylogenetic relationship than that between distant ones. Therefore, the system evolution of P. asparagi is related to the geographical distribution of its strains.
Collapse
Affiliation(s)
- Y Q Yang
- Institute of Plant Protection, Jiangxi Academy of Agricultural Sciences, Nanchang 330200, China
| | - Q Sun
- Huangdao Customs House, Qingdao 266555, China
| | - C M Li
- Jiangsu Lixiahe Institute of Agriculture Science, Yangzhou 225007, China
| | - H F Chen
- Institute of Plant Protection, Jiangxi Academy of Agricultural Sciences, Nanchang 330200, China
| | - F Zhao
- Huangdao Customs House, Qingdao 266555, China
| | - J H Huang
- Institute of Plant Protection, Jiangxi Academy of Agricultural Sciences, Nanchang 330200, China
| | - J S Zhou
- Institute of Vegetables and Flowers, Jiangxi Academy of Agricultural Sciences, Nanchang 330200, China
| | - X M Li
- Institute of Plant Protection, Jiangxi Academy of Agricultural Sciences, Nanchang 330200, China
| | - B Lan
- Institute of Plant Protection, Jiangxi Academy of Agricultural Sciences, Nanchang 330200, China
| |
Collapse
|
230
|
Arciero CA, Diehl AH, Liu Y, Sun Q, Gillespie T, Li X, Subhedar P. Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers. J Surg Oncol 2020; 122:1232-1239. [PMID: 32668059 PMCID: PMC10637266 DOI: 10.1002/jso.26129] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 06/22/2020] [Accepted: 06/29/2020] [Indexed: 02/06/2023]
Abstract
BACKGROUND AND METHODS Apocrine adenocarcinoma is a rare subtype of breast cancer. We sought to compare the characteristics and survival of patients diagnosed with triple-negative apocrine adenocarcinoma to those of patients diagnosed with triple-negative invasive ductal carcinoma. Utilizing data from the National Cancer Database between 2004 and 2013, 70 524 eligible female patients with triple-negative breast cancer were identified including 566 patients with apocrine adenocarcinomas and 69 958 patients with invasive ductal carcinoma. Descriptive statistics for each variable were reported. A comparison of each covariate between the study cohorts was assessed in univariate and multivariate analysis. Cox proportional models were used to calculate hazard ratios. Additionally, the propensity score matching method was implemented to reduce treatment selection bias. RESULTS Patients with triple-negative apocrine tumors were more likely to be older, Caucasian, and have smaller, moderately to well-differentiated tumors. Multivariable analysis noted a significantly improved survival for patients with triple-negative apocrine carcinoma (TNAC) vs triple-negative invasive ductal carcinoma (TNBC) (hazard ratio [HR] 0.65 [95% confidence interval [CI] [0.53-0.81], P = 0 < .001). Propensity score matching analysis confirmed a significant difference in overall survival for patients with TNAC in comparison to TNBC (HR 0.79 [95% CI [0.63-1.00], P = .05). DISCUSSION Triple-negative apocrine adenocarcinomas have a modestly improved long-term survival when compared with triple-negative invasive ductal cancers.
Collapse
Affiliation(s)
- Cletus A Arciero
- Department of Surgery, Division of Surgical Oncology, Emory University School of Medicine, Atlanta, Georgia
- Glenn Family Breast Center, Winship Cancer Institute, Atlanta, Georgia
| | | | - Yuan Liu
- Department of Surgery, Division of Surgical Oncology, Emory University School of Medicine, Atlanta, Georgia
- Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia
| | - Qin Sun
- Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia
| | - Theresa Gillespie
- Department of Surgery, Division of Surgical Oncology, Emory University School of Medicine, Atlanta, Georgia
- Glenn Family Breast Center, Winship Cancer Institute, Atlanta, Georgia
| | - Xiaoxian Li
- Glenn Family Breast Center, Winship Cancer Institute, Atlanta, Georgia
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia
| | - Preeti Subhedar
- Department of Surgery, Division of Surgical Oncology, Emory University School of Medicine, Atlanta, Georgia
- Glenn Family Breast Center, Winship Cancer Institute, Atlanta, Georgia
| |
Collapse
|
231
|
Sun Q, Xie J, Zheng R, Li X, Chen H, Tong Z, Du B, Qiu H, Yang Y. The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study. Int Immunopharmacol 2020; 90:107143. [PMID: 33208294 PMCID: PMC7604217 DOI: 10.1016/j.intimp.2020.107143] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Revised: 10/15/2020] [Accepted: 10/22/2020] [Indexed: 12/26/2022]
Abstract
ANXA3 is positively associated with infiltrated neutrophil–lymphocyte ratio (iNLR) in HCC. HCC patients with a high iNLR and high ANXA3 expression confer the highest risk of death. ANXA3 regulates the chemokine CXCL8 and CCL25 to remodel the iNLR and promotes tumourigenicity in HCC.
Background Thymosin α1 therapy was commonly used in patients with coronavirus disease 2019 (COVID-19), while its impact on outcomes and which patients could benefit from thymosin α1 therapy were uncertain. Study design and methods Patients with COVID-19 from 19 designated hospitals between January 1 to February 29, 2020 were included, and the main exposure of interest was administration of thymosin α1. The primary outcome was 28-day mortality. Propensity score matching (PSM) was used to account for baseline confounders, cluster analysis and Cox proportional hazard model was used to account for subgroup analysis. Results A total of 771 patients were included, and 327/771 (42.4%) patients received thymosin α1 therapy. The 28-day mortality in thymosin group was significantly lower than that in control group (41.3% vs. 60.6%, p < 0.001). After PSM 522 patients were included in analysis and the 28-day mortality in thymosin α1 group and control group were 51.0% and 52.9% respectively, with no significant difference. In subgroup analyses, the association between thymosin α1 therapy and 28-day mortality appeared to be stronger among male patients (HR 0.673, 95% CI 0.454–0.998; p = 0.049). There were no benefits of thymosin α1 in 28-day mortality in other subgroups. There were two phenotypes after cluster analysis, but no benefits of thymosin α1 were shown in phenotype 1 (HR 0.823 95% CI 0.581–1.166; p = 0.273) and phenotype 2 (HR 1.148 95% CI 0.710–1.895; p = 0.442). Conclusion There was no association between use of thymosin α1 and decreased mortality in critically ill COVID-19 patients. Subgroups analysis and phenotype analysis also showed no differences on mortality after thymosin α1 therapy.
Collapse
Affiliation(s)
- Qin Sun
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, No. 87, Dingjiaqiao Road, Gulou District, Nanjing 210009, PR China
| | - Jianfeng Xie
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, No. 87, Dingjiaqiao Road, Gulou District, Nanjing 210009, PR China
| | - Ruiqiang Zheng
- Department of Critical Care Medicine, Northern Jiangsu People's Hospital, School of Medicine, Yangzhou University, No. 98, Nantongxi Road, Guangling District, Yangzhou 225000, PR China
| | - Xuyan Li
- Department of Respiratory and Critical Care Medicine, Beijing Chao-yang Hospital, Capital Medical University, No. 8, Gongtinan Road, Chaoyang District, Beijing 100000, PR China
| | - Hui Chen
- Department of Critical Care Medicine, The First Affiliated Hospital of Soochow University, Soochow University, No. 899 Pinghai Road, Suzhou 215000, PR China
| | - Zhaohui Tong
- Department of Respiratory and Critical Care Medicine, Beijing Chao-yang Hospital, Capital Medical University, No. 8, Gongtinan Road, Chaoyang District, Beijing 100000, PR China
| | - Bin Du
- Department of Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 53, Dongdabei Road, Beijing 100000, PR China
| | - Haibo Qiu
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, No. 87, Dingjiaqiao Road, Gulou District, Nanjing 210009, PR China
| | - Yi Yang
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, No. 87, Dingjiaqiao Road, Gulou District, Nanjing 210009, PR China.
| |
Collapse
|
232
|
Ren W, Luo Z, Pan F, Liu J, Sun Q, Luo G, Wang R, Zhao H, Bian B, Xiao X, Pu Q, Yang S, Yu G. Integrated network pharmacology and molecular docking approaches to reveal the synergistic mechanism of multiple components in Venenum Bufonis for ameliorating heart failure. PeerJ 2020; 8:e10107. [PMID: 33194384 PMCID: PMC7605218 DOI: 10.7717/peerj.10107] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 09/15/2020] [Indexed: 01/13/2023] Open
Abstract
Venenum Bufonis (VB), also called Chan Su in China, has been extensively used as a traditional Chinese medicine (TCM) for treating heart failure (HF) since ancient time. However, the active components and the potential anti-HF mechanism of VB remain unclear. In the current study, the major absorbed components and metabolites of VB after oral administration in rats were first collected from literatures. A total of 17 prototypes and 25 metabolites were gathered. Next, a feasible network-based pharmacological approach was developed and employed to explore the therapeutic mechanism of VB on HF based on the collected constituents. In total, 158 main targets were screened out and considered as effective players in ameliorating HF. Then, the VB components-main HF putative targets-main pathways network was established, clarifying the underlying biological process of VB on HF. More importantly, the main hubs were found to be highly enriched in adrenergic signalling in cardio-myocytes. After verified by molecular docking studies, four key targets (ATP1A1, GNAS, MAPK1 and PRKCA) and three potential active leading compounds (bufotalin, cinobufaginol and 19-oxo-bufalin) were identified, which may play critical roles in cardiac muscle contraction. This study demonstrated that the integrated strategy based on network pharmacology and molecular docking was helpful to uncover the synergistic mechanism of multiple constituents in TCM.
Collapse
Affiliation(s)
- Wei Ren
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Zhiqiang Luo
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
| | - Fulu Pan
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China
| | - Jiali Liu
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Qin Sun
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Gang Luo
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Raoqiong Wang
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Haiyu Zhao
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
| | - Baolin Bian
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
| | - Xiao Xiao
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China
| | - Qingrong Pu
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Sijin Yang
- National Traditional Chinese Medicine Clinical Research Base, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China
| | - Guohua Yu
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
| |
Collapse
|
233
|
Shi M, Gu A, Tu H, Huang C, Wang H, Yu Z, Wang X, Cao L, Shu Y, Wang H, Yang R, Li X, Chang J, Hu Y, Shen P, Hu Y, Guo Z, Tao M, Zhang Y, Liu X, Sun Q, Zhang X, Jiang Z, Zhao J, Chen F, Yu H, Zhang W, Sun J, Li D, Zhou J, Han B, Wu YL. Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial. Ann Oncol 2020; 32:85-96. [PMID: 33130217 DOI: 10.1016/j.annonc.2020.10.479] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 09/25/2020] [Accepted: 10/15/2020] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND Polymeric micellar paclitaxel (pm-Pac) is a novel Cremophor EL-free, nanoparticle micellar formulation of paclitaxel. We aimed to compare the efficacy and safety between pm-Pac plus cisplatin and solvent-based paclitaxel (sb-Pac) plus cisplatin in advanced non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS A total of 448 stage IIIB to IV NSCLC patients were randomly assigned (2:1) to receive six 3-week cycles of either pm-Pac (230 mg/m2) plus cisplatin (70 mg/m2; n = 300), followed by dose escalation of pm-Pac to 300 mg/m2 from the second 3-week cycle if prespecified toxic effects were not observed after the first cycle, or sb-Pac (175 mg/m2) plus cisplatin (70 mg/m2; n = 148). The primary end point was objective response rate (ORR) assessed by independent review committees (IRCs). The secondary end points included IRC-assessed progression-free survival (PFS), overall survival (OS), and safety. RESULTS Patients in the pm-Pac-plus-cisplatin group showed significant improvements in IRC-assessed ORR compared with those in the sb-Pac-plus-cisplatin group (50% versus 26%; rate ratio 1.91; P < 0.0001). Additionally, subgroup analysis showed that a higher ORR was consistently observed in both squamous and nonsquamous histological types. IRC-assessed median PFS was significantly higher in the pm-Pac-plus-cisplatin group than in the sb-Pac-plus-cisplatin group (6.4-month versus 5.3-month; hazard ratio 0.63; P = 0.0001). Median OS was not significantly different between the two groups. The incidence of treatment-related serious adverse events (9% versus 18%; P = 0.0090) was significantly lower in the pm-Pac-plus-cisplatin group than in the sb-Pac-plus-cisplatin group. CONCLUSION Pm-Pac plus cisplatin yielded superior ORR and PFS along with a favorable safety profile and should become an option for patients with advanced NSCLC. CLINICAL TRIAL IDENTIFIER ClinicalTrials.gov NCT02667743; https://clinicaltrials.gov/ct2/show/NCT02667743.
Collapse
Affiliation(s)
- M Shi
- Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
| | - A Gu
- Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - H Tu
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China
| | - C Huang
- Department of Thoracic Oncology, Fujian Cancer Hospital, The Affiliated Cancer Hospital of Fujian Medical University, Fuzhou, China
| | - H Wang
- Department of Medical Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
| | - Z Yu
- Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China
| | - X Wang
- Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, China
| | - L Cao
- Department of Pneumology, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Hefei, China
| | - Y Shu
- Department of Oncology, Jiangsu Province Hospital, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
| | - H Wang
- Department of Medical Oncology, Tianjin Union Medical Centre, Tianjin, China
| | - R Yang
- Department of Tumor Chemotherapy, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Center, Kunming, China
| | - X Li
- Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Chang
- Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
| | - Y Hu
- Department of Medical Oncology, Hubei Cancer Hospital, Wuhan, China
| | - P Shen
- Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China
| | - Y Hu
- Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China
| | - Z Guo
- Department of Pneumology, Shanghai East Hospital, The Affiliated East Hospital of Tongji University, Shanghai, China
| | - M Tao
- Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China
| | - Y Zhang
- Department of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
| | - X Liu
- Department of Medical Oncology, Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-Sen University, Shantou, China
| | - Q Sun
- Department of Medical Oncology, Henan Provincial Chest Hospital, Zhengzhou, China
| | - X Zhang
- Department of Pneumology, The Affiliated Zhongshan Hospital of Fudan University, Shanghai, China
| | - Z Jiang
- Department of Medical Oncology, Puyang Oilfield General Hospital, Puyang, China
| | - J Zhao
- Department of Medical Oncology, The Affiliated Hospital of Qinghai University, Xining, China
| | - F Chen
- School of Public Health, Nanjing Medical University, Nanjing, China
| | - H Yu
- School of Public Health, Nanjing Medical University, Nanjing, China
| | - W Zhang
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - J Sun
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - D Li
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - J Zhou
- Shanghai Yizhong Biotechnical Co., Ltd., Shanghai, China
| | - B Han
- Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
| | - Y L Wu
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
| |
Collapse
|
234
|
Merkhofer C, Chennupati S, Sun Q, Eaton KD, Martins RG, Ramsey SD, Goulart BHL. Costs to healthcare payers associated with clinical trial (CT) participation in metastatic non-small cell lung cancer (NSCLC). J Clin Oncol 2020. [DOI: 10.1200/jco.2020.38.29_suppl.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3 Background: To assess the financial implications of therapeutic CT participation for healthcare payers, we compared first-line (1L) and second-line (2L) total direct medical costs between patients enrolled in 2L CT vs non-CT participants receiving 2L therapy for metastatic NSCLC. Methods: We linked electronic health records from a single academic center with tumor registry and claims data to identify patients with metastatic NSCLC diagnosed from 1/1/2007-12/31/2015. Eligibility criteria included 60 day minimum survival, receipt of ≥ 1 anti-cancer drug within 180 days of diagnosis, insurance enrollment for ≥ 12 months after diagnosis and receipt of ≥ 2 therapy lines. Patients on 1L trials were excluded. We calculated mean per-patient-per-month (PPPM) total direct medical costs from the payer perspective for 1L and 2L. We performed a difference-of-difference analysis to estimate the effect of trial enrollment on costs by calculating the mean PPPM difference between 2L and 1L in trial (Diff trial) and non-trial enrollees (Diff non-trial). Then we calculated the difference between Diff trial and Diff non-trial. We used paired and non-paired t-tests for statistical comparisons and report all costs in 2019 US dollars. Results: Of 63 patients, 22 (35%) enrolled in a 2L CT. CT enrollees were younger (mean age 63.5 vs 66.7 years), female (73% vs 41%), had commercial insurance (36% vs 32%), were never smokers (36% vs 32%), had EGFR mutations (27% vs 22%) and fewer had brain metastases (14% vs 29%). The mean PPPM total direct medical costs decreased between 2L and 1L for patients enrolled in 2L CTs but increased in non-trial participants (Diff trial = -$5,585, SD ± $6,541; Diff non-trial = $1,532, SD ± $14,739). The mean difference of difference (Diff trial - Diff non-trial) was -$7,117 (p = 0.01; Table). Conclusions: This small observational study suggests that CT enrollment results in substantial cost-savings to payers. If confirmed in larger studies, our findings suggest that insurers support trial participation for patients with NSCLC. [Table: see text]
Collapse
Affiliation(s)
| | | | - Qin Sun
- Fred Hutchinson Cancer Research Center, Seattle, WA
| | | | | | | | | |
Collapse
|
235
|
Li JY, Wei X, Sun Q, Zhao XQ, Zheng CY, Bai CX, Du J, Zhang Z, Zhu LG, Jia YS. MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2. Eur Rev Med Pharmacol Sci 2020; 23:6394-6403. [PMID: 31378877 DOI: 10.26355/eurrev_201908_18519] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE We aimed to explore the role of microRNA-449b-5p in osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and its mechanism of action. MATERIALS AND METHODS Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assay was used to detect the expression levels of microRNA-449b-5p and osteogenic markers including RUNX2, OCN during BMSCs differentiation. The microRNA-449b-5p mimic and microRNA-449b-5p inhibitors were transfected into BMSCs to achieve microRNA-449b-5p overexpression and knockdown, then the expressions of osteogenic markers were detected by qRT-PCR. The ALP activity staining and the alizarin red staining were used to detect the activity of ALP and the mineralization ability of cells after overexpression and knockdown of microRNA-449b-5p. Binding sites for microRNA-449b-5p and Satb2 were predicted by TargetScan, the PicTar and microRNAanda programs, and confirmed by dual-luciferase reporter gene assay. The relationship between microRNA-449b-5p and Satb2 was analyzed by QRT-PCR and Western blot. The microRNA-449b-5p inhibitor and shSATB2 lentivirus were simultaneously transfected in BMSCs, and the expression levels of RUNX2, OCN and ALP were detected by qRT-PCR and ALP activity assays. RESULTS microRNA-449b-5p expression gradually decreased during osteogenic differentiation. Overexpression of microRNA-449b-5p inhibited BMSCs differentiation by down-regulating ALP activity, RUNX2, and OCN expression, while the opposite result was observed after knockdown of microRNA-449b-5p. MicroRNA-449b-5p can bind to the 3'UTR end of Satb2, which was involved in the osteogenic differentiation of microRNA-449b-5p-regulated BMSCs, and silencing of Satb2 can abolish the positive effect of the microRNA-449b-5p inhibitor on osteoblasts differentiation. CONCLUSIONS microRNA-449b-5p could aggravate osteoporosis by inhibiting osteogenic differentiation of BMSCs through targeting Satb2.
Collapse
Affiliation(s)
- J-Y Li
- Department of Orthopaedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
236
|
Liang Q, Bao X, Sun Q, Zhang Q, Zou X, Huang C, Shen C, Chu Y. Imaging VOC distribution in cities and tracing VOC emission sources with a novel mobile proton transfer reaction mass spectrometer. Environ Pollut 2020; 265:114628. [PMID: 32806440 DOI: 10.1016/j.envpol.2020.114628] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2019] [Revised: 04/15/2020] [Accepted: 04/16/2020] [Indexed: 06/11/2023]
Abstract
Volatile organic compounds (VOCs) are important precursors of ozone (O3) and secondary organic aerosols (SOAs). Tracing VOC pollution sources is important for controlling VOC emissions and reducing O3 and SOAs. We built a novel mobile proton transfer reaction mass spectrometry (M-PTR-MS) instrument to image the distribution of VOCs and trace their emission sources in cities and industrial parks. The M-PTR-MS is composed of a vibration-resistant proton transfer reaction mass spectrometry (PTR-MS) with a global positioning system receiver, modified box vehicle, and geographic information system (GIS) software. The PTR-MS, mounted on a vehicle, sends VOC data and vehicle position information to the GIS software. These data are used to image the space distribution of VOCs in real time while the vehicle platform is in motion and the VOC sources are precisely traced using the GIS. The spatial data resolution of the M-PTR-MS is typically 0.8 m. The limits of detection, sensitivity, and repeatability of the M-PTR-MS are 43.5 ppt, 347 counts ppb-1, and 2.4% (RSD, n = 5), respectively. The intensity of reagent ions is stable over 8 h (RSD = 0.45%). Compared with commercial PTR-MS equipment, the M-PTR-MS demonstrated high consistency, with a correlation coefficient of 92.665%. Several field experiments were conducted in China using the M-PTR-MS. In one field experiment, the VOC distribution along three different routes was surveyed; the navigation monitoring lasted 1.8 h over a distance of 26.7 km at an average speed of 15 km h-1. The VOC sources in an industrial park were identified by analyzing the components near different factories. The main species from a VOC source in an underground garage was related to paint. The M-PTR-MS instrument can be used by environmental protection agencies to trace VOC pollution sources in real time, and by researchers to survey VOC emissions in regions of concern.
Collapse
Affiliation(s)
- Qu Liang
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China; University of Science and Technology of China, Hefei, 230026, China
| | - Xun Bao
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China; University of Science and Technology of China, Hefei, 230026, China
| | - Qin Sun
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China; University of Science and Technology of China, Hefei, 230026, China
| | - Qiangling Zhang
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China; University of Science and Technology of China, Hefei, 230026, China
| | - Xue Zou
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China
| | - Chaoqun Huang
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China
| | - Chengyin Shen
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China; Department of Pharmacy, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China.
| | - Yannan Chu
- Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China
| |
Collapse
|
237
|
Shayota BJ, Donti TR, Xiao J, Gijavanekar C, Kennedy AD, Hubert L, Rodan L, Vanderpluym C, Nowak C, Bjornsson HT, Ganetzky R, Berry GT, Pappan KL, Sutton VR, Sun Q, Elsea SH. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway. Mol Genet Metab 2020; 131:147-154. [PMID: 32828637 PMCID: PMC8630378 DOI: 10.1016/j.ymgme.2020.07.013] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2020] [Revised: 07/31/2020] [Accepted: 07/31/2020] [Indexed: 12/27/2022]
Abstract
Inborn errors of metabolism (IEM) involving the non-oxidative pentose phosphate pathway (PPP) include the two relatively rare conditions, transketolase deficiency and transaldolase deficiency, both of which can be difficult to diagnosis given their non-specific clinical presentations. Current biochemical testing approaches require an index of suspicion to consider targeted urine polyol testing. To determine whether a broad-spectrum biochemical test could accurately identify a specific metabolic pattern defining IEMs of the non-oxidative PPP, we employed the use of clinical metabolomic profiling as an unbiased novel approach to diagnosis. Subjects with molecularly confirmed IEMs of the PPP were included in this study. Targeted quantitative analysis of polyols in urine and plasma samples was accomplished with chromatography and mass spectrometry. Semi-quantitative unbiased metabolomic analysis of urine and plasma samples was achieved by assessing small molecules via liquid chromatography and high-resolution mass spectrometry. Results from untargeted and targeted analyses were then compared and analyzed for diagnostic acuity. Two siblings with transketolase (TKT) deficiency and three unrelated individuals with transaldolase (TALDO) deficiency were identified for inclusion in the study. For both IEMs, targeted polyol testing and untargeted metabolomic testing on urine and/or plasma samples identified typical perturbations of the respective disorder. Additionally, untargeted metabolomic testing revealed elevations in other PPP metabolites not typically measured with targeted polyol testing, including ribonate, ribose, and erythronate for TKT deficiency and ribonate, erythronate, and sedoheptulose 7-phosphate in TALDO deficiency. Non-PPP alternations were also noted involving tryptophan, purine, and pyrimidine metabolism for both TKT and TALDO deficient patients. Targeted polyol testing and untargeted metabolomic testing methods were both able to identify specific biochemical patterns indicative of TKT and TALDO deficiency in both plasma and urine samples. In addition, untargeted metabolomics was able to identify novel biomarkers, thereby expanding the current knowledge of both conditions and providing further insight into potential underlying pathophysiological mechanisms. Furthermore, untargeted metabolomic testing offers the advantage of having a single effective biochemical screening test for identification of rare IEMs, like TKT and TALDO deficiencies, that may otherwise go undiagnosed due to their generally non-specific clinical presentations.
Collapse
MESH Headings
- Adult
- Biomarkers/blood
- Carbohydrate Metabolism, Inborn Errors/blood
- Carbohydrate Metabolism, Inborn Errors/genetics
- Carbohydrate Metabolism, Inborn Errors/metabolism
- Carbohydrate Metabolism, Inborn Errors/pathology
- Child
- Child, Preschool
- Chromatography, Liquid
- Female
- Humans
- Infant
- Male
- Mass Spectrometry
- Metabolism, Inborn Errors/blood
- Metabolism, Inborn Errors/genetics
- Metabolism, Inborn Errors/metabolism
- Metabolism, Inborn Errors/pathology
- Metabolomics
- Pentose Phosphate Pathway/genetics
- Transaldolase/blood
- Transaldolase/deficiency
- Transaldolase/genetics
- Transaldolase/metabolism
- Transketolase/blood
- Transketolase/deficiency
- Transketolase/genetics
- Young Adult
Collapse
Affiliation(s)
- Brian J Shayota
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
| | - Taraka R Donti
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
| | - Jing Xiao
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Baylor Genetics, Houston, TX, USA
| | | | | | - Leroy Hubert
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
| | - Lance Rodan
- Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA
| | | | - Catherine Nowak
- Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA
| | - Hans T Bjornsson
- McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Landspitali University Hospital, Reykjavik, Iceland
| | - Rebecca Ganetzky
- Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | - Gerard T Berry
- Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA
| | | | - V Reid Sutton
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Baylor Genetics, Houston, TX, USA
| | - Qin Sun
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Baylor Genetics, Houston, TX, USA
| | - Sarah H Elsea
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Baylor Genetics, Houston, TX, USA.
| |
Collapse
|
238
|
Zhao H, Qin Y, Xiao Z, Li Q, Yang N, Pan Z, Gong D, Sun Q, Yang F, Zhang Z, Wu Y, Xu C, Qiu F. Loss of Function of an RNA Polymerase III Subunit Leads to Impaired Maize Kernel Development. Plant Physiol 2020; 184:359-373. [PMID: 32591429 PMCID: PMC7479876 DOI: 10.1104/pp.20.00502] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Accepted: 06/15/2020] [Indexed: 05/03/2023]
Abstract
Kernel size is an important factor determining grain yield. Although a number of genes affecting kernel development in maize (Zea mays) have been identified by analyzing kernel mutants, most of the corresponding mutants cannot be used in maize breeding programs due to low germination or incomplete seed development. Here, we characterized small kernel7, a recessive small-kernel mutant with a mutation in the gene encoding the second-largest subunit of RNA polymerase III (RNAPΙΙΙ; NRPC2). A frame shift in ZmNRPC2 leads to a premature stop codon, resulting in significantly reduced levels of transfer RNAs and 5S ribosomal RNA, which are transcribed by RNAPΙΙΙ. Loss-of-function nrpc2 mutants created by CRISPR/CAS9 showed significantly reduced kernel size due to altered endosperm cell size and number. ZmNRPC2 affects RNAPIII activity and the expression of genes involved in cell proliferation and endoreduplication to control kernel development via physically interacting with RNAPIII subunits RPC53 and AC40, transcription factor class C1 and Floury3. Notably, unlike the semidominant negative mutant floury3, which has defects in starchy endosperm, small kernel7 only affects kernel size but not the composition of kernel storage proteins. Our findings provide novel insights into the molecular network underlying maize kernel size, which could facilitate the genetic improvement of maize in the future.
Collapse
Affiliation(s)
- Hailiang Zhao
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| | | | - Ziyi Xiao
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| | - Qi Li
- National Key Laboratory of Plant Molecular Genetics, Chinese Academy of Science Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology & Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China
| | - Ning Yang
- State Key Laboratory of Plant Genomics, National Center for Plant Gene Research, Institute of Genetics and Developmental Biology, The Innovative Academy of Seed Design, Chinese Academy of Sciences, Beijing 100101, China
| | - Zhenyuan Pan
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| | - Dianming Gong
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| | - Qin Sun
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| | - Fang Yang
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| | - Zuxin Zhang
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| | - Yongrui Wu
- National Key Laboratory of Plant Molecular Genetics, Chinese Academy of Science Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology & Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China
| | - Cao Xu
- State Key Laboratory of Plant Genomics, National Center for Plant Gene Research, Institute of Genetics and Developmental Biology, The Innovative Academy of Seed Design, Chinese Academy of Sciences, Beijing 100101, China
| | - Fazhan Qiu
- National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Wuhan 430070, China
| |
Collapse
|
239
|
Zhou J, Fan J, Shi G, Huang X, Wu D, Yang G, Ge N, Hou Y, Sun H, Huang X, He Y, Qiu S, Yang X, Xu Y, Gao Q, Huang C, Lu J, Sun Q, Liang F. 56P Anti-PD1 antibody toripalimab, lenvatinib and gemox chemotherapy as first-line treatment of advanced and unresectable intrahepatic cholangiocarcinoma: A phase II clinical trial. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.034] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
240
|
McCleary BM, Trout AT, Dillman JR, Sun Q, Fei L, Abu-El-Haija M. Validation of threshold values for pancreas thickness and T1-weighted signal intensity ratio in the pediatric pancreas. Pediatr Radiol 2020; 50:1381-1386. [PMID: 32556574 DOI: 10.1007/s00247-020-04733-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Revised: 04/14/2020] [Accepted: 05/20/2020] [Indexed: 12/21/2022]
Abstract
BACKGROUND Pancreas atrophy and the loss of T1-weighted signal intensity by magnetic resonance imaging (MRI) are findings of chronic pancreatitis. OBJECTIVE The purpose of this study was to test published normal values and cutoffs for pancreas thickness and the pancreas:spleen T1-weighted signal intensity ratio in children without pancreatic disease. MATERIALS AND METHODS This was a secondary analysis of prospectively collected MRI data for 50 children (range: 6.3-15.9 years; 27 female) with no history of pancreatic disease. Two observers (R1, R2) measured linear pancreas thickness on axial T1-weighted, fat-saturated gradient recalled echo images and placed regions of interest in the pancreas and spleen to calculate the T1-weighted signal intensity ratio. Measurements were compared to published pediatric normal values (computed tomography [CT], ultrasound [US]) and adult cutoffs (CT, MRI). RESULTS Compared to published pediatric values for CT, 68% (R1: 34/50) or 40% (R2: 22/50) of participants had ≥1 pancreas segment with thickness below the normal range. No participant had a thickness value below the normal range published for US. Compared to cutoff values in adults, 84% (R1: 42/50) or 80% (R2: 40/50) of participants met the criteria for pancreas atrophy. Mean T1-weighted signal intensity ratio was 1.33±0.15 (R1) and 1.32±0.16 (R2). Twelve (R1: 24.5% of 49) or 11/49 (R2: 22.4%) participants had a T1-weighted signal intensity ratio below the threshold associated with exocrine insufficiency in adults. CONCLUSION Previously defined thresholds for pancreas thickness and pancreas:spleen T1-weighted signal intensity ratio appear too restrictive for a pediatric population. Further study is needed to define optimal quantitative metrics for findings of chronic pancreatitis in children.
Collapse
Affiliation(s)
- Brendan M McCleary
- Section of Pediatric Imaging, Cleveland Clinic Children's Hospital, Cleveland, OH, USA
| | - Andrew T Trout
- Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., MLC 5031, Cincinnati, OH, 45229, USA.
- Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
| | - Jonathan R Dillman
- Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., MLC 5031, Cincinnati, OH, 45229, USA
- Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA
| | - Qin Sun
- Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - Lin Fei
- Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - Maisam Abu-El-Haija
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| |
Collapse
|
241
|
Miles RC, Lee CI, Sun Q, Bansal A, Lyman GH, Specht JM, Fedorenko CR, Greenwood-Hickman MA, Ramsey SD, Lee JM. Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative. J Natl Compr Canc Netw 2020; 17:813-820. [PMID: 31319393 DOI: 10.6004/jnccn.2018.7281] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2018] [Accepted: 02/06/2019] [Indexed: 11/17/2022]
Abstract
BACKGROUND The purpose of this study was to assess advanced imaging (bone scan, CT, or PET/CT) and serum tumor biomarker use in asymptomatic breast cancer survivors during the surveillance period. PATIENTS AND METHODS Cancer registry records for 2,923 women diagnosed with primary breast cancer in Washington State between January 1, 2007, and December 31, 2014, were linked with claims data from 2 regional commercial insurance plans. Clinical data including demographic and tumor characteristics were collected. Evaluation and management codes from claims data were used to determine advanced imaging and serum tumor biomarker testing during the peridiagnostic and surveillance phases of care. Multivariable logistic regression models were used to identify clinical factors and patterns of peridiagnostic imaging and biomarker testing associated with surveillance advanced imaging. RESULTS Of 2,923 eligible women, 16.5% (n=480) underwent surveillance advanced imaging and 31.8% (n=930) received surveillance serum tumor biomarker testing. Compared with women diagnosed before the launch of the Choosing Wisely campaign in 2012, later diagnosis was associated with lower use of surveillance advanced imaging (odds ratio [OR], 0.68; 95% CI, 0.52-0.89). Factors significantly associated with use of surveillance advanced imaging included increasing disease stage (stage III: OR, 3.65; 95% CI, 2.48-5.38), peridiagnostic advanced imaging use (OR, 1.76; 95% CI, 1.33-2.31), and peridiagnostic serum tumor biomarker testing (OR, 1.35; 95% CI, 1.01-1.80). CONCLUSIONS Although use of surveillance advanced imaging in asymptomatic breast cancer survivors has declined since the launch of the Choosing Wisely campaign, frequent use of surveillance serum tumor biomarker testing remains prevalent, representing a potential target for further efforts to reduce low-value practices.
Collapse
Affiliation(s)
- Randy C Miles
- Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; and
| | - Christoph I Lee
- Department of Radiology, University of Washington Medical Center
| | - Qin Sun
- Fred Hutchinson Cancer Research Center
| | | | | | - Jennifer M Specht
- Department of Oncology, University of Washington Medical Center, and
| | | | | | | | - Janie M Lee
- Department of Radiology, University of Washington Medical Center
| |
Collapse
|
242
|
Peng F, Chang W, Sun Q, Xu X, Xie J, Qiu H, Yang Y. HGF alleviates septic endothelial injury by inhibiting pyroptosis via the mTOR signalling pathway. Respir Res 2020; 21:215. [PMID: 32795289 PMCID: PMC7427898 DOI: 10.1186/s12931-020-01480-3] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Accepted: 08/03/2020] [Indexed: 12/16/2022] Open
Abstract
Background Endothelial injury is one of the predominant pathophysiological characteristics of sepsis and is the major cause of sepsis-induced multiple organ failure. Endothelial pyroptosis is a fatal mechanism of endothelial injury in sepsis, and specific, effective therapies are lacking. Although hepatocyte growth factor (HGF) has been shown to have anti-apoptotic and anti-necrotic effects, whether it prevents pyroptosis to improve endothelial injury in sepsis remains unclear. Methods Recombinant HGF was intravenously injected into mice with sepsis caused by caecal ligation puncture (CLP). Histopathological examination and transmission electron microscopy (TEM) were used to measure lung vascular endothelial injury. Lipopolysaccharide (LPS) was transfected into EA.hy926 cells to induce endothelial pyroptosis, and the cells were treated with HGF in the presence of inhibitors of c-Met and mTOR, namely, PHA-665752 and rapamycin, respectively. The mTOR signalling pathway and mitochondrial physiology were assessed using Western blot and flow cytometry. Results Intravenous HGF effectively alleviated pulmonary vascular endothelial injury and acute lung injury in the septic mice. The TEM results of lung tissue revealed that HGF attenuated pulmonary vascular endothelial pyroptosis, which was confirmed in vitro. Transfected LPS induced the pyroptosis of EA.hy926 cells and damaged their paracellular permeability, and these effects were ameliorated by treating the cells with recombinant HGF. The protective effect of HGF against pyroptosis was dependent on c-Met/mTOR signalling. mTOR activation effectively protected mitochondrial physiology and decreased reactive oxygen species (ROS) production in EA.hy926 cells in vitro. Conclusions These results demonstrated that HGF protected mitochondrial physiology by activating mTOR signalling to partially ameliorate endothelial pyroptosis and attenuate vascular endothelial injury and acute lung injury in sepsis animal model.
Collapse
Affiliation(s)
- Fei Peng
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Nanjing, 210009, People's Republic of China
| | - Wei Chang
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Nanjing, 210009, People's Republic of China
| | - Qin Sun
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Nanjing, 210009, People's Republic of China
| | - Xinyi Xu
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Nanjing, 210009, People's Republic of China
| | - Jianfeng Xie
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Nanjing, 210009, People's Republic of China
| | - Haibo Qiu
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Nanjing, 210009, People's Republic of China
| | - Yi Yang
- Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Nanjing, 210009, People's Republic of China.
| |
Collapse
|
243
|
Stroup BM, Marom R, Li X, Hsu CW, Chang CY, Truong LD, Dawson B, Grafe I, Chen Y, Jiang MM, Lanza D, Green JR, Sun Q, Barrish JP, Ani S, Christiansen AE, Seavitt JR, Dickinson ME, Kheradmand F, Heaney JD, Lee B, Burrage LC. A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance. Hum Mol Genet 2020; 29:2171-2184. [PMID: 32504080 PMCID: PMC7399531 DOI: 10.1093/hmg/ddaa107] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2020] [Revised: 04/30/2020] [Accepted: 05/19/2020] [Indexed: 12/18/2022] Open
Abstract
Lysinuric protein intolerance (LPI) is an inborn error of cationic amino acid (arginine, lysine, ornithine) transport caused by biallelic pathogenic variants in SLC7A7, which encodes the light subunit of the y+LAT1 transporter. Treatments for the complications of LPI, including growth failure, renal disease, pulmonary alveolar proteinosis, autoimmune disorders and osteoporosis, are limited. Given the early lethality of the only published global Slc7a7 knockout mouse model, a viable animal model to investigate global SLC7A7 deficiency is needed. Hence, we generated two mouse models with global Slc7a7 deficiency (Slc7a7em1Lbu/em1Lbu; Slc7a7Lbu/Lbu and Slc7a7em1(IMPC)Bay/em1(IMPC)Bay; Slc7a7Bay/Bay) using CRISPR/Cas9 technology by introducing a deletion of exons 3 and 4. Perinatal lethality was observed in Slc7a7Lbu/Lbu and Slc7a7Bay/Bay mice on the C57BL/6 and C57BL/6NJ inbred genetic backgrounds, respectively. We noted improved survival of Slc7a7Lbu/Lbu mice on the 129 Sv/Ev × C57BL/6 F2 background, but postnatal growth failure occurred. Consistent with human LPI, these Slc7a7Lbu/Lbu mice exhibited reduced plasma and increased urinary concentrations of the cationic amino acids. Histopathological assessment revealed loss of brush border and lipid vacuolation in the renal cortex of Slc7a7Lbu/Lbu mice, which combined with aminoaciduria suggests proximal tubular dysfunction. Micro-computed tomography of L4 vertebrae and skeletal radiographs showed delayed skeletal development and suggested decreased mineralization in Slc7a7Lbu/Lbu mice, respectively. In addition to delayed skeletal development and delayed development in the kidneys, the lungs and liver were observed based on histopathological assessment. Overall, our Slc7a7Lbu/Lbu mouse model on the F2 mixed background recapitulates multiple human LPI phenotypes and may be useful for future studies of LPI pathology.
Collapse
Affiliation(s)
- Bridget M Stroup
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Ronit Marom
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
- Texas Children's Hospital, Houston, TX 77030, USA
| | - Xiaohui Li
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Chih-Wei Hsu
- Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Cheng-Yen Chang
- Department of Medicine-Pulmonary, Baylor College of Medicine, Houston, TX 77030, USA
| | - Luan D Truong
- Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA
| | - Brian Dawson
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Ingo Grafe
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
- Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III, Center for Healthy Aging, University Clinic, Dresden D-01307, Germany
| | - Yuqing Chen
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Ming-Ming Jiang
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Denise Lanza
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Jennie Rose Green
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Qin Sun
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
- Baylor Genetics, Houston, TX 77021, USA
| | - J P Barrish
- Department of Pathology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA
| | - Safa Ani
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Audrey E Christiansen
- Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA
| | - John R Seavitt
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Mary E Dickinson
- Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Farrah Kheradmand
- Department of Medicine-Pulmonary, Baylor College of Medicine, Houston, TX 77030, USA
| | - Jason D Heaney
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Brendan Lee
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
| | - Lindsay C Burrage
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
- Texas Children's Hospital, Houston, TX 77030, USA
| |
Collapse
|
244
|
Yodoshi T, Orkin S, Arce Clachar AC, Bramlage K, Sun Q, Fei L, Beck AF, Xanthakos SA, Trout AT, Mouzaki M. Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. J Pediatr 2020; 223:93-99.e2. [PMID: 32711755 PMCID: PMC8017767 DOI: 10.1016/j.jpeds.2020.04.046] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Revised: 03/31/2020] [Accepted: 04/16/2020] [Indexed: 12/11/2022]
Abstract
OBJECTIVE To investigate the association between muscle mass and liver disease severity in pediatric patients with non-alcoholic fatty liver disease (NAFLD). STUDY DESIGN This was a retrospective study of patients aged <20 years followed from 2009 to 2018. Muscle mass was estimated in all patients by measuring magnetic resonance imaging-based total psoas muscle surface area (tPMSA) and correcting for height (tPMSA index = tPMSA/height2). Two cohorts were studied, one with histological confirmation of NAFLD (n = 100) and the other with magnetic resonance imaging (MRI) evidence of hepatic steatosis (n = 236). Histology was scored using Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) criteria. MRI-measured proton density fat fraction (PDFF) and liver stiffness were collected. Demographic, clinical, and socioeconomic status (using a validated Community Deprivation Index [CDI]) were assessed as covariates. Univariate regression analyses, followed by multivariable regression analyses, were used to determine the relationships between tPMSA index and NAS, MRI-PDFF, and liver stiffness, adjusting for clinical, demographic, and CDI variables. RESULTS In the multivariable regression analyses, higher steatosis score was associated with a lower tPMSA index (OR, 0.73; 95% CI, 0.56-0.96) and younger age (OR, 0.84; 95% CI, 0.73-0.97). Liver PDFF was also significantly associated with the tPMSA index (P = .029), sex (P = .019), and CDI (P = .005). In contrast, liver stiffness was not associated with tPMSA in multivariable analyses. CONCLUSIONS tPMSA index was independently associated with both imaging and histological features of hepatic steatosis severity in children. Future studies should directly explore the presence and directionality of causative links between muscle mass and steatosis, as well as whether interventions that enhance muscle mass can reduce disease severity in children with NAFLD.
Collapse
Affiliation(s)
- Toshifumi Yodoshi
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Sarah Orkin
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Ana-Catalina Arce Clachar
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Kristin Bramlage
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Qin Sun
- Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Lin Fei
- Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Andrew F. Beck
- Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,James M. Anderson Center for Health Systems Excellence, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Division of General and Community Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Division of Hospital Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Stavra A. Xanthakos
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Andrew T. Trout
- Department of Radiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Marialena Mouzaki
- Division of Gastroenterology, Hepatology, and Nutrition, University of Cincinnati College of Medicine, Cincinnati, OH; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
| |
Collapse
|
245
|
Li JJ, Zhu YJ, Sun Q, Su QJ. [Teratocarcinosarcoma of nasal cavity: report of a case]. Zhonghua Bing Li Xue Za Zhi 2020; 49:497-498. [PMID: 32392941 DOI: 10.3760/cma.j.cn112151-20190823-00462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- J J Li
- Department of Pathology, the 940th Hospital of the Joint Logistic Support of the People's Liberation Army, Lanzhou 730050, China; Department of Pathology and Pathophysiology,Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
| | - Y J Zhu
- Department of Pathology, the 940th Hospital of the Joint Logistic Support of the People's Liberation Army, Lanzhou 730050, China; Department of Pathology and Pathophysiology,Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
| | - Q Sun
- Department of Pathology and Pathophysiology,College of Basic Medicine of Lanzhou University, Lanzhou 730000, China
| | - Q J Su
- Department of Pathology, the 940th Hospital of the Joint Logistic Support of the People's Liberation Army, Lanzhou 730050, China
| |
Collapse
|
246
|
Sun Q, Nie HH, Su HF, Yang SY, Teo BK. Synthesis, Structures, and Photoluminescence of Elongated Face-Centered-Cubic Ag 14 Clusters Containing Lipoic Acid and Its Amide Analogue. Inorg Chem 2020; 59:8836-8845. [PMID: 32551557 DOI: 10.1021/acs.inorgchem.0c00592] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Three face-centered-cubic (fcc) silver clusters-namely, [Ag14(LA)2(HLA)4(PPh3)8]2- (1), [Ag14(HLA)6(PPh3)8] (2), and [Ag14(NLA)6(PPh3)8] (3)-that are coprotected by lipoic acid (or its amide derivative) and phosphine ligands have been synthesized and structurally characterized (HLA = (±)-α-lipoic acid, LA = (±)-α-lipoate, and NLA = d,l-6,8-thioctamide). These clusters possess two superatomic electrons (the Jellium model), in harmony with a bonding octahedral Ag6 core capped with 8 Ag atoms. Alternatively, the metal framework of 1-3 can be described as adopting a face-centered cubic (fcc) structure elongated along one of the 3-fold axes. The 12 S atoms from the six bioligands bridge the 12 edges of the (fcc) cube, forming a distorted icosahedron. The counterions, solvent or guest molecules play an important role in dictating the crystal lattices of the products. This is the first report of atom-precise structures of Ag-lipoic acid (or its derivatives) clusters, paving the way for further study of structure-property relationships of these bioligand protected metal nanoclusters. Photoluminescence was observed for cluster 3 with complex temperature-dependent emission patterns and efficiencies.
Collapse
Affiliation(s)
- Qin Sun
- Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian, China
| | - Hong-Hong Nie
- Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian, China
| | - Hai-Feng Su
- Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian, China
| | - Shi-Yao Yang
- Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian, China
| | - Boon K Teo
- Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian, China
| |
Collapse
|
247
|
Sun Q, Ren I, Zaki T, Maciejewski K, Choate K. 432 Ichthyosis affects mental health in adults and children: A cross-sectional study. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
248
|
Azmony L, Sun Q, Hamilton C, Lim Y, Leventhal J, Paller A, Choate K. 868 Pathogenesis based therapy improves cutaneous abnormalities in porokeratosis- A pilot study. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
249
|
Zhang Y, Yan J, Sun Q. 763 Exosomes derived from human umbilical cord mesenchymal stem cells relieve psoriasis-like skin inflammation. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
250
|
Yodoshi T, Arce-Clachar AC, Sun Q, Fei L, Bramlage K, Xanthakos SA, Flores F, Mouzaki M. Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease. J Pediatr 2020; 222:127-133. [PMID: 32381466 PMCID: PMC8218655 DOI: 10.1016/j.jpeds.2020.03.038] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Revised: 02/20/2020] [Accepted: 03/17/2020] [Indexed: 02/07/2023]
Abstract
OBJECTIVES To determine the prevalence of renal impairment in a large cohort of youths with histologically confirmed nonalcoholic fatty liver disease (NAFLD), and to determine its association with liver disease severity. STUDY DESIGN Clinical, laboratory, and histology data were collected retrospectively in a pediatric cohort with biopsy-confirmed NAFLD at a tertiary care center between 2010 and 2017. Histological NAFLD severity was scored using validated criteria. Glomerular filtration rate (GFR) was calculated and categorized as low (<90 mL/min/1.73 m2), normal (90-136 mL/min/1.73 m2), or high (>136 mL/min/1.73 m2). Univariate and multivariate modeling were used to determine differences between the GFR groups and to control for confounders. RESULTS The cohort comprised 179 patients (82% non-Hispanic; median age; 14 years; IQR, 12-16 years). One-third of the patients had abnormal renal function, including 36 (20%) with glomerular hyperfiltration and 26 (15%) with low GFR. In multivariable logistic regression, compared with normal GFR, hyperfiltration was independently associated with higher NAFLD activity score (aOR, 2.96; 95% CI, 1.49-5.87; P = .002), after adjusting for age, sex, ethnicity, obesity severity, presence of type 2 diabetes mellitus, and medications. CONCLUSIONS In this large cohort with histologically confirmed NAFLD, renal impairment was highly prevalent and associated with liver disease severity, independent of obesity severity. Screening patients with confirmed NAFLD for renal complication is recommended.
Collapse
Affiliation(s)
- Toshifumi Yodoshi
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Ana Catalina Arce-Clachar
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH
| | - Qin Sun
- Division of Biostatistics and Epidemiology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Lin Fei
- Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH,Division of Biostatistics and Epidemiology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Kristin Bramlage
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Stavra A. Xanthakos
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH,Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH
| | - Francisco Flores
- Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH,Division of Nephrology and Hypertension, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Marialena Mouzaki
- Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH.
| |
Collapse
|